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ABSTRACT 
This study explores the impact of direct-to-consumer television (DTC) prescription 
drug advertisements on physicians' attitudes toward the pharmaceutical products featured in 
those ads and their tendency to prescribe those products. In doing so, it examines doctors' 
responsiveness to patient requests resulting from exposure to such ads. It applies the tenets 
of the diffusion of innovations theory and the two-step flow hypothesis to better understand 
the role of patient-doctor interpersonal interaction on physicians' prescription-writing 
tendencies. 
This study was inspired by Petroshius, Titus and Hatch (1995) who explored the 
impact of physicians' attitudes toward pharmaceutical company advertising on physicians' 
prescription drug writing habits and responsiveness to patient requests. The current inquiry 
replicates the Petroshius et al. study's objectives although it is a bit more specific in its 
purpose, focusing on television DTC ads. 
A self-administered questionnaire was sent to 210 licensed Iowa physicians who are 
general or family practitioners. The physicians were randomly selected from the 2004 Iowa 
Medical Society Directory. 
The findings showed that Iowa physicians are not in favor of televised DTC 
advertising of prescription products. Furthermore, the results support a revised version of the 
two-step flow: physicians' attitudes are directly linked and are important contributors to their 
tendencies to prescribe a product their patients learned about from ads they saw on television. 
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CHAPTER 1. INTRODUCTION 
The skyrocketing cost of prescription drugs has become a heated topic in American 
society today, often making it to political campaign agendas. Petitioned by their constituents, 
lawmakers at all levels are addressing constitutional concern over the ever-increasing 
prescription drug costs that threaten health care. Amidst this scenario, citizens are witnessing 
more and more advertising of prescription drugs on television, the Internet and in print. 
THE ADVENT OF DIRECT-TO-CONSUMER TELEVISON ADVERTISING 
"The FDA generally interprets the term 'advertisement' to cover information other 
than labeling that promotes a product. The term includes promotions broadcast on television 
or radio, conducted by telephone, or printed in magazines or newspapers" (Nordenberg, 
1998, p. 8). However, an extensive history surrounds the evolution of the advertising of 
prescription products. 
Until fairly recently, advertising of prescription products was directed exclusively at 
healthcare professionals. However, statutes regarding the advertising of food and drugs have 
been enacted since the early 1900s. 
The Wiley Act, also known as the Pure Food and Drug Act of 1906, was the first 
federal legislation enacted to regulate food and drugs. Since labels under which drugs were 
sold were the primary medium for drug promotions, advertising in other channels lagged 
behind. False statements on labels regarding ingredients and/or the effects of the drug were 
considered the foremost criteria for a misbranding claim, even though drug companies were 
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not mandated to prove those claims (Palumbo & Mullins, 2002). Palumbo & Mullins (2002) 
explain that: 
False claims for a drug that were not on the label were not prohibited by the 1906 
Act, thus creating a loophole that could allow unsafe drug products to remain on the 
market. Moreover, although the Federal Trade Commission Act of 1914 gave the 
Federal Trade Commission (FTC) jurisdiction over advertising practices generally, 
the FTC did not have the authority to regulate deceptive advertisements unless it 
could prove that such advertisements injured another company. (p. 425) 
The Federal Food, Drug and Cosmetic Act (FDCA) of 1938 later replaced the Wiley Act. 
Between the years of 1906 and 1938, great changes in the pharmaceutical industry and 
advances in technology, and consequently advertising, took place. The development of the 
radio at that time elevated advertising to a new level, creating a need for consumer protection 
from fraudulent claims (Palumbo & Mullins, 2002). "Congress was concerned not only with 
dangerous products on the market, but with false marketing claims as well" (Palumbo & 
Mullins, 2002, p. 425). 
Congress then delegated to the FDA jurisdiction over the labeling of all drugs, but 
amended the Federal Trade Commission Act in 1938 to move the jurisdiction over all drug 
advertising to the FTC (Palumbo & Mullins, 2002). Before 1951, pharmaceutical products 
were not classified as prescription or non-prescription drugs. Even though pharmacists 
generally did not dispense most drugs without a prescription, law did not require a 
prescription, except in the case of narcotics (Palumbo & Mullins, 2002). 
The year 1951 marked a turning point when "the Durham-Humphrey amendments to 
the FDCA required drugs that are not safe for use except under medical supervision to be 
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dispensed only by prescription of a licensed practitioner" (Palumbo & Mullins, 2002, p. 426). 
Palumbo & Mullins (2002) add: 
The amendments had a two-fold objective: to protect the public from abuses in the 
sale of potent prescription drugs, and to relieve pharmacists and consumers from 
burdensome and unnecessary restriction on the dispensing of drugs that can be taken 
safely without the supervision of a physician. (p. 426) 
In 1962, the Kefauver-Harris Drug amendments to the FDCA transferred authority 
over prescription drug advertising from the FTC to the FDA, while the supervision of over-
the-counter (OTC) drug advertising was left to the FTC (Palumbo & Mullins, 2002). Since 
1962, the FDA has regulated the advertising of prescription drug products under the Federal 
Food, Drug and Cosmetic Act and other related regulations (Nordenberg, 1998). Under the 
1962 Kefauver-Harris Amendments to the Federal Food, Drug, and Cosmetic Act, 
advertisements must have four basic attributes: 
(1) they cannot be false or misleading; (2) they must present a "fair balance" of 
information about the risks and benefits of using the drug; (3) they must contain 
"facts" that are "material" to the product's advertised uses; and (4) in general, the 
advertisement's "brief summary" of the drug must include every risk from the 
products approved labeling. (Henney, 1999, p. 2242) 
For many years, the advertising and promotion of prescription drugs have been 
directed exclusively at health care professionals. "However, the FDA's 1985 decision to lift 
the moratorium on the advertising of prescription drugs to consumers has changed the 
dynamics of the physician's decision process regarding which drugs to prescribe" (Petroshius 
et al., 1995, p. 41). Even though the FDA lifted the moratorium on prescription drug 
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advertisements in 1985, the pharmaceutical industry did not rush to promote drugs directly to 
consumers (Alperstein & Peyrot, 1993). In October 1995, the FDA began holding public 
hearings concerning DTC promotion. Two years later, the FDA issued the 'Draft Guidance 
for Industry, Consumer-Directed Broadcast Advertisements' in which facilitated 
manufa~turer dissemination ofDTC promotions through the broadcast media (Palumbo & 
Mullins, 2002). Consequently, television ads featuring prescription drugs significantly 
increased. The FDA guidelines were amended in 1997, allowing pharmaceutical 
manufacturers more flexibility in providing information about the risks advertised 
prescription products might engender. In 1999, the FDA released its Final Guidance 
informing the public that it would not consider "a broadcast advertisement to be in violation 
if it complies with the Guidance" (Palumbo & Mullins, 2002, p. 430). 
Since the release of the FDA' s Guidance, consumers saw a new wave of 
pharmaceutical advertising and promotion directed at them. "The advent of such consumer-
direct pharmaceutical advertising affords patients the opportunity to be better informed about 
their prescribed medication options" (Petroshius et al., 1995, p. 41 ). 
Before the Guidance was released, the first television direct-to-consumer (DTC) 
prescription drug ad for the nicotine patch was aired during the 1992 Super Bowl. The 
resulting demand for the patch soon exceeded the supply. The success of the initial DTC ads, 
pharmaceutical marketers aired similar ads for treatments of osteoporosis and genital herpes. 
The results were much the same (Holmer, 1999). 
Not surprisingly, since the FDA granted pharmaceutical companies more flexibility in 
their broadcast promotions, pharmaceutical marketers have budgeted ever-increasing 
amounts of money to advertise their products to consumers. In recent years, DTC advertising 
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as whole has exploded, with spending rising from $12 million in 1989 to $2.38 billion in 
2001 (Palumbo & Mullins, 2002). More specifically, "pharmaceutical DTC spending for 
network, cable, spot and syndicated television advertising has risen steadily from $309.6 
million in 1997 to $664.4 million in 1998 and $1. l billion in 1999" (Henderson & Hatfield, 
2001, p. 1). 
While other mass media channels are utilized to bring about consumer awareness of 
prescription drugs, the case ofDTC television advertising of prescription drugs has triggered 
newfound awareness among consumers. "Consequently, it is not surprising that whenever 
you tum on your television you will probably see at least one pharmaceutical ad promising 
relief from allergies, arthritis, depression, sexual dysfunction, or a host of other medical 
maladies" (Henderson & Hatfield, 2001, p. 1 ). Indeed, the frequency of televised 
consumer-directed advertisements of prescription drugs appears to be increasing over time as 
indicated by the increasing advertising allocations with each passing year. 
The FDA is finalizing draft guidances for drug labeling before formulating guidances 
for Internet DTC advertising. "The agency wants to improve more traditional advertising 
vehicles before writing guidelines for newer media such as the Internet. The comment period 
for the draft guidances ends May 10, when the FDA will begin crafting the final guidances" 
(The Food & Drug Letter, ii 3, 2004). 
DTC advertising of prescription drugs is executed through various forms of media, 
including print and the Internet. However, significant differences exist between televised 
DTC prescription drug ads compared to other forms, such as that of print and the Internet. 
DTC advertising of prescription drugs via television are typically contained in 
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30- or 60-second spots. Prescription drug advertisements aired on television may state the 
purpose of the drug as well as note the possible side-effects of the drug, yet television ads do 
not contain complete summaries of information concerning the drug that are included in 
other forms of media such as print. 
The FDA recognizes three broad categories of prescription drug advertisements. 
These three categories include: reminder advertisements, help-seeking or disease-oriented 
advertisements, and product-claim advertisements (Palumbo & Mullins, 2002). "Reminder 
advertisements call attention to the name of the drug product, but do not include 
specifications of the drug product" (Palumbo & Mullins, 2002, p. 428-429). Help-seeking 
ads are also known as "see your doctor" ads. These ads do not mention a specific drug's 
name, but describe symptoms of a disease or condition. These ads encourage consumers to 
consult their physicians regarding treatment options (Palumbo & Mullins, 2002). "Product-
claim advertisements reveal the drug's name and indication, and thus satisfy the brief 
summary requirements and maintain fair balance" (Palumbo & Mullins, 2002, p. 429). Until 
1997 when the FDA amended its guidelines to include greater flexibility in providing 
information about the risks of the drugs advertised, pharmaceutical marketers had a much 
more difficult time creating ads that met FDA guidelines. Among others, they should relay 
risk information in a television spot lasting only 30 or 60 seconds. 
DTC television advertisements of prescription drugs reach millions of television 
viewers every day. Patients often do not have to do anything more than watch television to 
become aware of medications. As a result of televised DTC ads featuring drugs, "consumers 
in many cases now find themselves with sufficient information to directly affect the choice of 
which medication is ultimately prescribed by physicians" (Petroshius et al., 1995, p. 41). 
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Like other industries that advertise their products, pharmaceutical companies have the 
right to inform people about their products in accordance with FDA regulations. However, 
consumers obtain the product without the authority of a physician. The fact remains that a 
patient needs a prescription from a physician in order for any drug to be obtained legally. 
Ultimately, the decision as to what to prescribe lies in the hands of the physician. 
Because pharmaceutical companies have directed their efforts in the past to get 
medical doctors to adopt their products, one may question why pharmaceutical companies 
are now, more than ever, directing their promotions toward consumers. In advertising most 
any product, the goal of marketers is for consumers to try and ultimately purchase and adopt 
the specific product being advertised. By directly advertising prescription drugs to 
consumers, are pharmaceutical companies attempting to influence the adoption of advertised 
drug products through patients? What role does DTC television advertising play in helping 
physicians determine what drugs to prescribe? Do physicians have a tendency to prescribe 
drugs that are featured in the televised ads? Do their patients request the drugs advertised? 
If so, how often? 
Presently, intense debate exists concerning the impact ofDTC advertising of 
prescription products. Why is it that only the United States and New Zealand allow DTC 
advertising of prescription products? (Mintzes et al., 2002). "On the rationale that such 
advertising provides important information to consumers and patients may benefit from 
advertised products, pharmaceutical manufacturers have campaigned in the European Union 
and Canada for the relaxing of current regulatory restrictions" (Mintzes et al., 2002, p. 278). 
Are other countries facing the same controversy as the United States since it relaxed its rules 
regarding DTC advertising? 
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Concern about the effects ofDTC ads has been a priority of the FDA. Jane E. 
Henney, MD, Commissioner of the FDA, sums it up by saying that: 
There has always been one central question surrounding DTC advertisements of 
prescription medications: Do these advertisements provide consumers with 
information that empowers them to care for their health, or are they misleading in a 
way that presents a public health hazard? (Henney, 1999, p. 2242) 
Without a doubt, consumer spending on prescription products has increased by an 
astounding 86% between 1997 and 2001 (Kaiser Family Foundation, 2003). As prescription 
products become less affordable to citizens, many question what exactly is driv~ng the price 
up. Some place the blame on DTC advertising and the money pharmaceutical marketers 
spend to advertise their products. 
A report commissioned by the Kaiser Family Foundation (2003) and conducted by 
researchers at the Harvard School of Public Health, the Massachusetts Institute of 
Technology and the Harvard Medical School, provide insights into the impact ofDTC 
advertising on prescription drug spending. The Kaiser Family Foundation study (2003) 
examined changes in DTC advertising and physician promotion activities from 1996 to 1999, 
and their effects on the sales of five therapeutic drug classes. 
The findings do not necessarily imply that DTC advertising is the key culprit in the 
ever-increasing cost of prescription drugs. Rather, the study notes (2003) that, "there are 
several components to this rapid rise in spending: more prescriptions are being written, prices 
of existing drugs are rising, and higher-priced new drugs are replacing existing drugs" (p. 2). 
U.S. prescription drug spending has more than tripled between 1997 and 2001, when 
it reached $140.6 billion. In line with the rise in total expenditures by pharmaceutical 
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companies, the promotional spending has also risen significantly. According to the Kaiser 
Family Foundation study (2003), promotional spending for pharmaceuticals has more than 
doubled since 1996 to 2001, from $9.2 billion to $19.1 billion, an annual average rate of 
about 16%. Although advertising contributes to drug costs, it must be noted that DTC 
advertising is, and remains, a relatively small part of pharmaceutical market promotions 
(Kaiser Family Foundation, 2003). Promotions directed at physicians still make up the 
majority of pharmaceutical spending. The study also indicates that DTC advertising only 
makes up about 14% of prescription product promotional spending in comparison to 
sampling, making up about 55% of the budget, and detailing about 29% (Kaiser Family 
Foundation, 2003). The study concluded that "DTC advertising is an important, but not 
primary, driver of growth in prescription drug spending" (p. 8). 
Concerns about DTC advertising, especially on television, go beyond objections to 
the rising costs of prescription products. Former 2004 Democratic presidential candidate 
Howard Dean called for a ban on DTC prescription drug advertising during his campaign as 
part of his six-point plan to reduce prescription drug costs. According to an article featured 
in Advertising Age (2003): 
Mr. Dean said drug advertising "occasionally ... has a legitimate purpose of informing 
consumers about a new product that can benefit them. More commonly, it simply 
increases the demand for these products, dramatically increasing the nation's 
prescription drug bill. I support a ban on direct advertising of prescription drugs to 
consumers except for situations where there is a compelling public health justification 
for advertising." (if 3) 
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Advertising Age was quick to point out that the ad industry groups challenged the Dean 
campaign, continuing to def end the value of DTC ads to the public. 
The onslaught of televised DTC ads prompted scholars to examine the impact of such 
advertising on patient-physician relationships. 
Since DTC ads first appeared in 1997, critics have argued that they marginalize the 
doctor-patient relationship by encouraging patients to pressure doctors into writing 
prescriptions for an advertised drug. Critics contend that this raises drug costs and 
leads to overmedication of patients and drug abuse. (The Food & Drug Letter, 2004, if 
28) 
.Another study by Christenson et al. (1997) noted that: 
Those opposed to consumer advertising of prescription drugs claim detrimental health 
effects. They believe consumers' limited understanding of risk and susceptibility to 
the promotional aspects of drug advertising will induce them to put pressure on 
physicians to prescribe inappropriately. Further the opposition believes physicians 
will respond to this pressure causing stimulated drug misuse in an over-medicated 
society. (p. 1589) 
Studies have also concluded that DTC ads "typically minimize the risks and overstate the 
benefits of pharmaceutical products" (Carey, 2004, p. 84). 
Hardesty (1988, p. 44) also wrote about the changing dynamics of the patient-
physician relationship. They conclude that: 
Public education has eroded a professional monopoly of knowledge and has increased 
patient's skepticism about the physician's knowledge claim (Wilensky, 1964; Haug. 
1976). For instance, patient awareness of new drugs, new therapies and new medical 
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technology has increased patient demands. Patient requests for certain diagnostic 
tests are "a way ofrejecting [the] authority of the physician in favor of the authority 
of technology (Haug, 1976, p. 95). (p. 44) 
While some are concerned about the negative effects ofDTC advertising on the patient-
physician relationship, proponents argue the benefits. Christenson et al. (1997) wrote: 
Proponents of consumer drug advertising claim that advertising increases patient 
awareness of the existence of disease, availability of treatment, and potential 
side effects associated with specific drugs. The claimed overall effect of increased 
patient awareness is greater patient participation in drug therapy decisions and risk 
assessment. Further, proponents claim that greater patient participation in drug 
therapy decisions might lead to better compliance with prescribed drug regimens. (p. 
1598) 
The American Medical Association (AMA) noted that current DTC advertising practices 
"indicate a slant towards benefits rather than risks" (The Food & Drug Letter, 1 16, 2004). 
The AMA went one step further in its comments, citing studies by Duke University cognitive 
science professor Ruth Day that said "many DTC television ads were constructed so that 
viewers retained indication and benefits information much better than side effects and risk 
information" (1 16). The AMA has been recently reported saying that "surveys have shown 
DTC ads increase physician office visits; the same surveys show some patients demand 
specific advertised drugs from their physicians" (The Food & Drug Letter, 119, 2004). 
The patient-physician relationship is important because almost everyone at one time 
or another requires the care of a physician. A study conducted by Petroshius et al. focused 
on physicians' attitudes toward the advertising of prescription drugs, including cosmetic 
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pharmaceuticals, and the impact of these attitudes on physician prescription-writing habits, 
responsiveness to patient requests, and attention to pharmaceutical ads (Petroshius et al., 
1995). The purpose of the study was to explore the impact of physicians' attitudes toward 
pharmaceutical company advertising on prescription writing habits and responsiveness to 
patient requests. The findings of this study suggested that physicians are favorable to the 
advertising of pharmaceutical products to both consumers and physicians (Petroshius et al., 
1995). While this study worked to gauge physicians' attitudes towards pharmaceutical 
advertising in general, the influences of these general attitudes on behavior and their 
responsiveness to consumer prescription inquiries and requests have yet to be documented 
(Petroshius et al., 1995). 
The Diffusion of Prescription Drug Use 
The diffusion of innovations, championed by Everett Rogers (1995), is defined as a 
general process in which innovations are communicated through certain channels over time 
among members of a social system. According to his formulation, the innovation-decision 
process generally consists of five stages: 
1. Knowledge occurs when an individual (or other decision-making unit) is exposed 
to an innovation's existence and gains some understanding of how it functions. 
2. Persuasion occurs when an individual (or some other decision-making unit) forms 
a favorable or unfavorable attitude toward the innovation. 
3. Decision occurs when an individual (or some other decision-making unit) engages 
in activities that lead to a choice to adopt or reject the innovation. 
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4. Implementation occurs when an individual (or other decision-making unit) puts an 
innovation into use. 
5. Confirmation occurs when an individual (or some other decision-making unit) 
seeks reinforcement of an innovation-decision already made, or reverses a 
previous decision to adopt or reject the innovation if exposed to conflicting 
messages about.the innov_ation. (p. 20) 
As far back as the 1950s, the innovation-decision process has been applied 
specifically to medical innovations. Katz, Menzel and Coleman (1966) studied the adoption 
of medical innovations in their work, Medical Innovation: A Diffusion Study. They surveyed 
216 doctors in four midwestem communities to trace the patterns of diffusion of a new drug 
as it gained acceptance in the medical community. Their analysis centered on the channels of 
information about a drug used by doctors, and their influences on the subsequent stages 
leading to adoption or rejection. Based on their findings they developed a model of the 
stages in the diffusion of a new drug in a medical community. Their model involved a locus 
of diffusion that progresses through the following five stages: 
1) Diffusion through dense professional ties 
2) Diffusion through dense friendship ties 
3) Diffusion to relatively isolated doctors 
4) Individual adoption unaffected by ties to colleagues 
5) Few further adoptions. (p. 131) 
Abbott and Yarbrough (1999) explain that when this model is applied, 
One of the key generalizations that has emerged is that different channels of 
communication play key roles at different points in the adoption process. Mass media 
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play their key role in bringing about initial awareness and knowledge of new ideas 
and practices, while interpersonal sources are relied upon when deciding whether or 
not to adopt. (p.l) 
However, with the advent ofDTC advertising, the components of this model as applied to 
drug adoption by physicians becomes more complicated. Because consumers are now also 
directly targeted by prescription drug advertisements, particularly through television, doctors 
today have to deal with consumer awareness of prescription drugs. As consumers become 
increasingly aware of prescription drugs through DTC advertising, is there a possibility that 
an additional locus of diffusion could be added to Coleman, Katz and Menzel's diffusion 
stages for drug innovations? Their study did not take into account DTC advertising, its 
impact on consumers, and how patients relay that information to physicians. Advertising at 
that time, was directed exclusively at physicians. 
The physicians' responsiveness to consumer prescription drug inquiries noted in the 
Petroshius et al. (1995) study, and the effects of patient/consumer awareness of prescription 
drugs in the innovation-decision process as a result of DTC ads inspire this study and its 
mode of inquiry. Going beyond the physicians' attitudes regarding pharmaceutical drug 
advertising, this study analyzes the attitudes and responsiveness of physicians to patients' 
inquiries and requests regarding prescription drugs they have seen on television. The 
information flow of interest here is as follows: 
DTC ads -7 patients -7 physicians 
It is therefore pertinent to ask: 
1. Do physicians' attitudes toward television DTC prescription product advertising influence 
their tendencies to write prescriptions for products featured in those ads? 
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2. How do physicians perceive the extent to which patients are exposed to DTC television 
ads promoting prescription products? 
3. Are physicians responding to their patients' demands for advertised products by 
prescribing the products featured in the television ads? 
4. Do demographic variables have a bearing on physicians' attitudes regarding televised 
DTC advertising of prescription products? 
5. Do demographic variables have a bearing on physicians' behavioral tendencies to write 
prescriptions for drugs advertised in DTC television ads? 
6. Does the frequency with which their patients refer to television ads influence physicians' 
tendencies to prescribe drugs featured in the ads? 
This study explores an aspect of the communication relationship between physicians 
and patients. Because most everyone at some time or another requires a doctor's care and 
treatment based on prescription drugs, both patients and physicians can benefit from a better 
understanding of the dynamics of this relationship. The study attempts to reveal if patients 
are discussing their medical treatment options with their physicians in part due to televised 
DTC prescription advertisements. It might be of interest to them to know how their doctors 
generally respond to those inquiries. Doctors, on the other hand, can better gauge how much 
influence DTC television advertising has on their patients and how that exposure influences 
what he/she prescribes for them. 
This study will also aid pharmaceutical marketers who are constantly assessing 
whether their advertising efforts reach their objectives. The results of the study should help 
assess whether DTC television advertising of prescription drugs serves both the promotional 
interest of the pharmaceutical industry as well as public health needs. This study also hopes 
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to contribute to the body of diffusion research pertinent to the medical field. If the ads are 
indeed making patients aware of their prescription drug options, and if this awareness factors 
into their interpersonal communication with their physicians, another stage could be added to 
Coleman et al.' s (1966) locus of diffusion model. This study proposes that the locus of 
diffusion moves from (1) those who develop the drugs to (2) those who market them using 
DTC ads (3) to the general public who inquires about those drugs from their physicians, ( 4) 
whose drug-prescribing behaviors are affected by their patients' inquiries. 
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CHAPTER 2. LITERATURE REVIEW 
Televised DTC advertising of prescription drugs is a relatively new phenomenon that 
is becoming more pervasive today. Tum on the television, and one is likely to see at least 
one prescription drug ad within 15 minutes. Billions of dollars are budgeted each year by 
pharmaceutical companies to market their drugs to consumers even though a prescription is 
required for consumers to purchase such advertised products. 
Indeed, DTC advertising of prescription drugs has played a key role in the newfound 
awareness of prescription drugs by consumers. However, long before DTC advertisements, 
doctors have been bombarded with information from pharmaceutical companies that are 
promoting the adoption of their products. As a result, the concept of "doctor dilemma" was 
coined as far back as the 1960s to describe how "a new mode of therapy, or a new drug, thus 
represents the doctor with a new set of uncertainties" (Coleman et al., 1966, p. 11). Even 
before advertising was directed at consumers, doctors were faced with the burden of coping 
with patients' inquiries regarding the drugs prescribed to treat their health problems. 
Whether knowledgeable patients seem a desirable thing or not, it is clear that patients 
who know more, or think they have a right to know, are [more] demanding in the 
sense that their demands are more concrete. In other words, they intensify the 
doctor's dilemma, for he not only has more patients, but patients who demand more 
of him. To satisfy their demands for knowledge, he needs to spend even more time 
keeping up scientifically. (Coleman, et al., 1966, p. 13) 
Today consumer awareness of prescription drugs is at an all-time high largely due to 
heightened DTC television advertising. The "doctor dilemma" noted by Coleman et al. 
18 
(1966) is likely to be an even greater burden as more patients "know more" or "think they 
have the right to know" about their drug treatments. 
Indeed, beyond patients' attitudes, today's physicians have to deal with consumer 
awareness of prescription drugs whether such knowledge is accurate or not. While it is clear 
that DTC prescription television ads may make consumers aware of the products advertised, 
it is uncertain whether the ads indeed make consumers more knowledgeable about the 
products. 
The two-step flow theory that was spawned by the diffusion of innovation research 
hypothesizes that influences stemming from the mass media first reach "opinion leaders" 
who, in tum, pass on what they read and hear to their every day associates to whom they are 
influential (Katz, 1957). Diffusion is defined as the "process by which an innovation is 
communicated through certain channels over time among members of a social system" 
(Rogers, 1995, p. 5). The two-step flow and diffusion studies both serve as analytical tools in 
this study to understand the impact of television DTC prescription drug ads on physicians' 
prescription-writing tendencies. 
THE DIFFUSION OF INNOVATIONS FRAMEWORK 
The diffusion theory is often used to understand how new ideas are transmitted from 
their original source until they are accepted and ultimately adopted. Although Rogers has 
been actively involved with diffusion research since 1954, problems concerning the diffusion 
of innovations have existed for a long time with the theory's roots extending back to the 
European beginnings of social science (Rogers, 1983). 
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Forms of diffusion studies can be traced back to 1903 with Gabriel Tarde's The Laws 
of Imitation. Tarde, a French judge labeled as one of the forefathers of sociology and social 
psychology, sought "to learn why, given 100 different innovations conceived at the same 
time - innovations in the form of words, in mythological ideas, in industrial processes, etc.-
ten will spread abroad while 90 will be forgotten" (Rogers, 1995, p. 40). Soon after Tarde, a 
group of anthropologists in England, Germany and Austria focused on the idea that 
"diffusion was the point of view in anthropology that explained social change in a given 
society as a result of the introduction of innovations from another society" (Rogers, 1995, p. 
41). 
These early social scientists helped lay the foundation for the strong diffusion 
research tradition prevailing today in anthropology, sociology, rural sociology, education, 
public health and medical sociology, communication, marketing and geography (Rogers, 
1995). 
The functions of communication channels have been elaborated upon in the diffusion 
process. "Interpersonal channels are more effective in persuading an individual to accept a 
new idea, especially if the interpersonal channel links two or more individuals who are 
similar in socioeconomic status, education or other important ways" (Rogers, 1995, p. 18). 
An innovation is usually assessed through the subjective evaluations of near-peers who have 
adopted the innovation. The near-peers serve as social models whose innovation behavior 
tends to be imitated by others in their system (Rogers, 1995). 
While a few diffusion studies were conducted during the 1920s and 1930s, it was the 
Ryan and Gross (1943) investigation of the diffusion of hybrid seed com that influenced the 
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methodology, theoretical framework, and interpretations oflater scholars (Rogers, 1995). It 
has been described as one of the most influential diffusion studies of all time. 
In 1941, two rural sociologists at Iowa State University, Bryce Ryan and Neil Gross, 
personally interviewed 259 farmers living in two small communities. Each of the 
respondents was asked to recall when and how they had adopted hybrid com and provide 
certain information about themselves and their farm operations (Rogers, 1995). The findings 
of the study led to a realization that the innovation-decision process involved considerable 
deliberation by most adopters. It was also found that communication channels played 
different roles at various stages in the innovation-decision process. "The typical farmer first 
heard of hybrid seed from a salesman, but neighbors were the most frequently cited channel 
leading to persuasion" (Rogers, 1995, p. 34). The Ryan and Gross (1943) study set a 
precedent in the study of diffusion that expanded beyond elaboration exploration, not only in 
rural sociology disciplines, but also into almost all other research realms (Rogers, 1983). 
"Ryan and Gross launched 15 of the 18 most widely used intellectual innovations in the rural 
sociology diffusion research tradition" (Rogers, 1995, p. 35). This led Katz (1960) to 
proclaim a convergence of the communications and rural sociology disciplines in recognition 
of the impact of the theoretical framework in the social sciences. "The realization of the 
shared interest in the problem of campaigns--or, more accurately now, in the shared 
problems of diffusion-has evidently overcome academic insulation." 
THE TWO-STEP FLOW OF COMMUNICATION 
In an effort to understand the innovation-decision process, scholars have formulated 
the "two-step flow of communication" from the findings of a number of studies, including 
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Merton's study of interpersonal influence and communications behavior in Rovere, New 
Jersey; the Decatur, Illinois study of decision-making in marketing, fashions, movie-going 
and public affairs reported by Katz and Lazarsfeld; the Elmira, New York study of the 1948 
election campaign reported by Berelson, Lazarsfeld and McPhee; and the Coleman, Katz and 
Menzel study on the diffusion of a new drug among doctors (Katz, 1957). 
The two-step flow hypothesizes that influences stemming from the mass media first 
reach "opinion leaders" who, in turn, pass on what they read and hear to their everyday 
associates to whom they are influential (Katz, 1957). While these studies lay the framework 
for the two-step flow hypothesis, each study has dealt with interpersonal .relations differently 
in their research designs (Katz, 1957). Even though the two-step flow has been amended in a 
number of ways, the studies are in consensus as they all "deal with decision and action, 
which is to say that they assess the short-run effects of mass communications in the context 
of campaigns. And on the whole, their findings remain valid" (Katz, 1987, p. S26). 
The original two-step flow hypothesis originated from the People 's Choice voting 
study in 1940. The study was concerned almost exclusively with the flow of influence from 
person to person (Katz & Lazarsfeld, 1966). Three distinct sets of findings were derived from 
the study that contributed substantially to the two-step flow hypothesis. The first finding 
deals with the impact of personal influence. The second has to do with the fl.ow of personal 
influence, and the third dealt with opinion leaders and the mass media (Katz, 1957). While 
the People's Choice study did produce significant results, "the design of the study did not 
anticipate the importance interpersonal relations would assume in the analysis of the data" 
(Katz, 1957, p. 62). 
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The People's Choice study inspired other researchers to further examine the two-step 
flow hypothesis and build upon it. Katz (1957) identified the following as the seminal works 
in this regard: 
1. The Rovere Study. Undertaken just as the 1940 voting study was being 
completed, the earliest of the three studies was conducted in a small town in New 
Jersey. It began by asking a sample of 86 respondents to name the people to 
whom they turned for information and advice regarding a variety of matters. 
Hundreds of names were mentioned in response, and those who were designated 
four times or more were considered opinion leaders. These influential people 
were then sought out and interviewed (Katz, 1957). 
2. The Decatur Study, carried out in 1945-46, tried to go a step further. Like the 
voting study, but unlike Rovere, it tried to account for decisions-specific 
instances in which the effect of various influences could be discerned and 
assessed. Like Rovere, but unlike the voting study, it provided for interviews 
with the person whom individuals in the initial sample had credited as influential 
in the making of recent decisions in the realms of marketing, movie-going, and 
public affairs. The focus of the study this time was not on the opinion leaders 
alone, but (a) on the relative importance of personal influence, and (b) on the 
person who named the leader as well as the leader-the advisor-advisee dyad (p. 
66). 
Combining this interest in diffusion with that of the role of more elaborate social networks of 
communication gave birth to a new study that focused on the diffusion of a specific item over 
time through the social structure of an entire community (Katz, 1957). 
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3. The Columbia Drug Study. Conducted to determine the way in which doctors 
make decisions whether to adopt new drugs. This study was carried out at the 
Bureau of Applied Social Research of Columbia University, the study took place 
during the 1950s and was published in 1957. Coleman, Katz and Menzel worked 
to design a study that would take into account the possible role of interpersonal 
influence among physicians. In doing so, it became clear that it was feasible to 
interview all members of the medical profession in several cities. If all doctors 
were interviewed, then there would be no doubt that all advisor-advisee pairs 
would fall within the context of larger social groupings of doctors, which could be 
measured by sociometric methods (Katz, 1957). As a result, a total of 216 doctors 
in four midwestem communities were interviewed, constituting 64 percent of all 
doctors in private practice in these cities. The results of the study suggested a 
multi-step process of the diffusion of a new drug through a medical community 
that specifically takes into account the influences of professional ties, friendship 
ties, isolated doctors, individual adoption unaffected by ties to colleagues and 
other studies. 
In reviewing these studies, Katz (1957) elaborates on the two-step flow 
hypothesis: 
From the several studies reviewed, it is clear that these very same 
interpersonal relations influence the making of decisions in at least two 
additional ways. In addition to serving as networks of communications, 
interpersonal relations are also sources of pressure to conform to the group's 
way of thinking and acting, as well as sources of social support. Thus, 
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interpersonal relations are (1) channels of information, (2) sources of social 
pressure, and (3) sources of social support, and each relates interpersonal 
relations to decision making in a somewhat different way. (p. 77) 
THE COLUMBIA DRUG STUDY: A CLOSER LOOK 
The 1950s marked a significant time in the diffusion tradition as well as medical 
sociology. Medical innovations, like that of new drugs or other medical techniques where 
the adopters are doctors, became the focus of study. 
In the field of medical sociology, the study by Menzel and Katz conducted in May 
1954 is instructive. The study came about when Joseph Precker, director of Market research 
at Pfizer Drug Company, approached the Bureau of Applied Social Research to determine 
whether they should continue to advertise a new drug in the Journal of the American Medical 
Association (Glock, 1979, p. 27) (Rogers, 1997). Bureau staff member Elihu Katz had 
already drafted a research proposal to study social networks and the influential sources 
within them (Rogers, 1997). "Pfizer's rather prosaic advertising question was merged with 
the basic idea of the Katz snowball proposal to create an investigation that represented a 
major advance in understanding the diffusion of innovations" (Rogers, 1997, p. 299). The 
merger of these two ideas gave birth to the Columbia drug study, known as one of the most 
valuable diffusion studies of all time (Rogers, 1997). 
The general undertaking included a pilot study centered on physician's reactions to 
innovations in therapy, particularly regarding new drugs (Menzel & Katz, 1956). The pilot 
study was conducted in a New England community with some 30 doctors (Coleman et. al, 
1966). The study worked to trace the diffusion of a new drug through the social structure of 
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the medical community and took into account the various ways interpersonal relations may 
"intervene" in the communication process (Menzel & Katz, 1956). Specifically, the study 
considers the way in which a doctor's position in the social structure of his local medical 
fraternity affects his acceptance of new pharmaceutical products (Menzel & Katz, 1956). 
The importance of interpersonal relations was found to be applicable to decision-
making (;lillong specialists concerning matters based on scientific findings in which well-
recognized expert sources of knowledge exist (Menzel & Katz, 1956). In conclusion, Katz 
and Menzel (1956) wrote: 
Finally we have found it necessary to propose amendments for the model of the two-
step flow of communications by considering the possibility of multi-step rather than 
two-step flow; by noting that sources other than printed publications may be the 
channels to the outside world maintained by the opinion leaders; by noting that the 
model may not apply to channels of low prestige and unusually easy accessibility; 
and by differentiating various kinds of leadership, especially by emphasizing the 
differential roles of the innovator or pioneer on the one hand and the opinion leader 
on the other. (p. 352) 
After analyzing the results of the pilot study, the full-scale study was designed and conducted 
among 216 doctors in four midwestem communities (Coleman et al., 1966). The study 
focused on the ongoing social processes that contribute to the eventual widespread adoption 
of a drug. 
Data were collected 15 months after a new drug with wide potential use, here called 
"gammanym," had been placed on the market. By this time almost all the doctors in 
relevant specialties in the four cities studied had used the drug, some almost 
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immediately, others only after a considerable interval of time. The research problem, 
stated most concretely, is this: "What were the social processes which intervened 
between the initial trials of the drug by a few local innovators and its final use by 
virtually the whole medical community?" (Coleman et al., 1966, p. 253) 
The findings of the study suggest that there are successive stages in the diffusion of 
innovations through the community of doctors (Coleman et. al, 1957). The chains of 
influence that connect the doctors in the professional relationships of advisors and discussion 
partners make friendship networks operative. As Table 1 indicates, those doctors are 
influenced in their decisions more by colleagues they meet as friends than by those they look 
to as advisors or who they talk to during working hours (Coleman et al., 1957). Social 
networks appear to be inoperative for those who do not adopt six months after the drug has 
been released. Interestingly, Coleman et al. (1966) found that doctors did not perceive drug 
companies as credible sources about a new drug. However, when the social structure has 
exhausted its effect on the diffusion of a medical innovation and when those doctors do 
finally use the drug, they do so "in response to influences outside the social network, such as 
detail men, ads, j oumals, and so on, and not in response to their relations with [other] 
doctors" (Coleman et al., 1957). 
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Table 1. Sources of information to which doctors turn in questions of therapya 
Sources of Information % to Whom Doctors Turn 
Local colleagues 43 % 
Professional Journals 34% 
Books 34% 
Literature, unspecified 17% 
Out-of-town medical sources 13% 
Commercial compendia 11% 
Pharmaceutical house organs 9% 
Meetings or conventions 5% 
Abstracting service or Q. and A. service 20% 
a The responses add to more than 100% because some doctors mentioned more than one 
source. 
Note. From Medical Innovation: A Diffusion Study (p. 62), by Coleman, J.S., Katz, 
E., and Menzel, H., 1966. Copyright 1966 by Bobbs-Merrill. 
Through their study, Coleman, Katz and Menzel (1966) were able to develop a model 
of the diffusion of a new drug through a medical community involving five stages. The 
stages are described by the locus of diffusion, statistical indicators, and time of adoption 
(months after the release of gammanym). They found that a new drug diffuses through a 
medical community (Coleman et al.1966) following five stages: 
1) Diffusion through dense professional ties 
2) Diffusion through dense friendship ties 
3) Diffusion to relatively isolated doctors 
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4) Individual adoption unaffected by ties to colleagues 
5) Few further studies 
Taken together, the results of the Coleman et al. (1966) study suggest a diffusion process that 
can be summarized as follows: 
At first the influence of these social networks operated only among the doctors who 
were integrated into the community to their colleagues through ties of a professional 
nature-as advisors or as discussion partners. Then it spread through the friendship 
network to doctors who were closely tied to the medical community through their 
friendship relations. By this time, social influence had also become operative in the 
"open" parts of the social structure-i.e., among the relatively isolated doctors. 
Finally there came a phase during which most of the remaining doctors introduced 
gammanym but did so in complete independence of the time at which their associates 
had introduced it; the networks now showed no effect (p. 268). 
RECENT STUDIES 
Indeed, diffusion studies have evolved over the years. Today, there are even more 
sources of influence than were identified in the Columbia drug study on doctors outside of 
their social networks. The promotion of prescription drugs to consumers through the media 
was not an issue when the Columbia drug study was conducted. Researchers are now turning 
their attention to analyze the effects of a relatively new phenomenon, the consumer-directed 
advertising of prescription drugs. 
The impact of medical innovations on the patient-physician relationship has been a 
topic of concern for researchers. In particular, a study conducted by Petroshius, Titus and 
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Hatch (1995) focused attention on physicians' attitudes toward the advertising of prescription 
drugs, including cosmetic pharmaceuticals, and the impact of these attitudes on the 
physicians' prescription-writing habits, responsiveness to patient requests, and attention to 
pharmaceutical ads (Petroshius, et al., 1995). The study involved a survey that was 
conducted among physicians in Ohio, Michigan and Indiana. A self-administered 
questionnaire was hand-delivered to 250 doctor's offices by one of five pharmaceutical 
representatives as part of their regular visit. The representatives then asked the physicians if 
they would complete the 10-15 minute questionnaire (Petroshius et al., 1995). The 
questionnaire consisted of Likert-scale items measuring the independent and dependent 
variables (see Appendix G). The Petroshius et al. study was designed to meet the following 
research objectives: 
1. To determine if there is a relationship between physicians' attitudes toward 
pharmaceutical company advertising of both cosmetic and medicinal products, 
and their tendency to prescribe such advertised products. 
2. To determine if there is a relationship between physicians' attitudes toward 
pharmaceutical company advertising of both cosmetic and medicinal products, 
and their responsiveness to patients' requests for prescription drugs. 
3. To determine if there is a relationship between physicians' attitudes toward 
pharmaceutical company advertising of prescription drugs of both cosmetic and 
medicinal products, directed toward consumers and practicing physicians. 
4. To determine if important group differences exist with respect to physicians' 
attitudes toward the advertising of prescription drug pharmaceuticals (e.g., 
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physician specialty, age, experience, practice type, and location). (Petroshius et 
al., 1995, p. 42) 
The Petroshius et al. study is, in essence, an exploratory examination of physicians' 
attitudes toward DTC pharmaceutical advertising. The findings of the study suggested that, 
overall, the physicians were favorable toward the advertising of pharmaceuticals and 
cosmetic pharmaceuticals although differences were found among physician sub-groups (i.e., 
by age, how long they had practiced, and their expertise as internists). The results also 
revealed that physicians' attitudes toward pharmaceuticals and cosmetic pharmaceutical ads 
have an impact on the amount of attention given to pharmaceutical ads, on physician drug-
writing habits, and on the responsiveness of the physician to patient requests (Petroshius et 
al., 1995). "While overall, physicians' attitudes toward the advertising of pharmaceuticals 
and cosmetic pharmaceuticals were favorable, significant differences were found among 
various physician sub-groups" (Petroshius et al., 1995). The study found that in general, 
older physicians, those in practice more than 20 years, and internists are less favorable 
toward pharmaceutical advertising and advertising of cosmetic pharmaceuticals and report 
being less attentive to and influenced by advertising as well as patient requests for such 
advertised drugs. Other differences occurred with respect to the type of practice the 
physician was in (group versus private) as well as the practice setting (urban, suburban or 
rural). 
Older physicians, those in practice over 20 years, and those specializing in internal 
medicine, were significantly less favorable toward pharmaceutical advertising than 
were younger physicians, those in practice less than 20 years, and those in other 
specialties. These differences were particularly pronounced with respect to 
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advertising directed toward consumers. Further, private practice physicians viewed 
pharmaceutical advertising significantly less favorably than those in group practice. 
Finally, physicians in urban settings had the most positive attitudes toward 
advertising to both consumers and physicians, with doctors practicing in rural areas 
holding the least favorable attitudes, particularly with respect to advertising directed 
at consumers. (Petroshius et al., 1995, p. 45) 
Overall physicians were found to hold relatively positive attitudes toward pharmaceutical 
companies advertising to both physicians and consumers. "In general, the findings suggest 
that physicians' attitudes toward pharmaceutical advertising are good predictors of which 
physicians are most likely to attend to such ads and likely to be responsive to patient 
inquiries and requests for advertised pharmaceuticals" (Petroshius et al., 1995, p. 47). 
While the study did reveal some interesting findings concerning physicians' attitudes 
toward pharmaceutical ads, "future research needs to be conducted to take the results of this 
study one step further and consider physicians' attitudes toward, and the relative 
effectiveness of, different forms of consumer-directed advertising" (Petroshius et. al., 1995, 
p. 50). 
A great deal has changed since the Petroshius study was published in 1995. The FDA 
amended its guidelines in 1997 to allow manufacturers who advertise prescription 
medications on television more flexibility in providing information about the risks of the 
drugs being promoted, hence making way for far more DTC advertising, especially via 
television. Subsequent studies are necessary to explore if physicians' attitudes toward DTC 
advertising of prescription drugs have changed since the Petroshius et al. study. 
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Building upon the findings of previous studies concerning the diffusion of 
prescription drugs in the medical community, especially among doctors, a set ofresearch 
questions is posed. The questions expand on those asked in the Petroshius et al. (1995) study 
by focusing specifically on DTC television advertising of prescription drugs rather than just 
DTC advertising of prescription drugs in general. Taking into account the previous studies 
concerning diffusion and the two-step flow, this study asks: 
RQl: Do physicians' attitudes toward televised DTC prescription product advertising 
influence their tendencies to prescribe products featured in such advertisements? 
RQ2: How do physicians perceive the extent to which patients are exposed to DTC 
television ads promoting prescription products? 
RQ3: Do physicians whose patients demand advertised products prescribe those 
products promoted in the televised ads as suggested by their patients? 
RQ4: Do individual demographic variables have a bearing on physicians' attitudes 
toward televised DTC prescription product advertising? 
RQS: Do individual demographic variables have a bearing on the tendencies of 
physicians to write prescriptions for products that are featured in televised ads? 
RQ6: Does the frequency with which patients refer to television ads influence 
physicians' tendencies to prescribe drugs featured in the ads? 
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CHAPTER3.METHODOLOGY 
Since the FDA's 1985 decision to lift the moratorium on the advertising of 
prescription drugs to consumers and the release of its Final Guidance in 1999, DTC ads on 
prescription drugs have become a fixture in television. Although the first televised DTC 
prescription drug ad for the nicotine patch did not air until the 1992 Superbowl, numerous 
prescription drug ads are now aired each day. 
DTC advertising of prescription drugs is a relatively new phenomenon whose effects 
are still subject to empirical research. Past studies have provided some insights into 
consumers' attitudes toward such advertising. However, there is still a dearth of research 
literature dealing with specific forms ofDTC advertising and their impact on target 
populations such as physicians. "Further, the influence of these generalized attitudes on 
physician [drug-] prescribing behavior and their responsiveness to consumer prescription 
inquiries and requests has yet to be documented" (Petroshius et al., 1995). 
This study is an extension of the Petroshius, Titus and Hatch study (1995) that was 
conducted to explore the impact of physicians' attitudes toward pharmaceutical company 
advertising on doctors' prescription drug writing habits and responsiveness to patient 
requests. However, while the Petroshius et al. study was among the first to examine 
physicians' attitudes toward prescription drug advertisements, the authors point out that 
"future research needs to be conducted to take the results of this study one step further and 
consider physicians' attitudes toward, and the relative effectiveness of, different forms of 
consumer-directed advertising" (Petroshius, et al., 1995, p. 50). The current inquiry 
replicates this study's objectives although it is a bit more specific in its purpose. The purpose 
34 
of the current study is to explore the impact of DTC television prescription drug ads on 
physicians' prescription writing habits and responsiveness to patient requests that may have 
resulted from people's exposure to televised prescription drug ads. Specifically, this study is 
designed to meet the following objectives: 
1. To determine whether there is a tendency among physicians to prescribe drugs 
that are advertised to consumers on television. 
2. To determine whether there is a relationship between physicians' attitudes toward 
pharmaceutical company advertising of prescription drugs and their 
responsiveness to patients' requests for prescription drugs. 
3. To determine whether there is a relationship between the frequency of patients 
citing television prescription drug ads and physicians' tendencies to prescribe 
drugs featured in those ads. 
4. To determine whether physicians' attitudes toward DTC television advertising of 
prescription products and their prescription-writing tendencies for those products 
differ according to their specialty, age, experience, practice type, and practice 
location (whether urban, suburban or rural). 
RESEARCH DESIGN 
Data for this study was gathered through a survey of physicians throughout the state 
of Iowa. A self-administered questionnaire was mailed to the addresses of 210 physicians. 
'The cover letter petitioned the physicians to take ten minutes of their time to complete the 
enclosed questionnaire. The cover appealed to the physicians' altruistic values, emphasizing 
that their participation will provide information that will help communication specialists 
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examine a relatively new area of research on communication effects, and that their responses 
will be used to understand how pharmaceutical information could best be provided to 
consumers (Petroshius, et al., 1995). The physicians were then asked to return the completed 
questionnaire by mail using the stamped self-addressed envelope included in the original 
mailing. 
SAMPLING 
The research objectives demanded an examination of a sample of physicians who are 
likely to receive requests for prescription products advertised on television. As such, 
physicians with family and general practice specialties were the population selected to be 
surveyed. 
A list of doctors licensed in the state oflowa who specialize in family and/or general 
practice was compiled using the Iowa Medical Society 2004 Membership Directory, a 
comprehensive listing that includes the contact information for all licensed physicians in the 
state who are members of the Iowa Medical Society (IMS). The IMS is the professional 
association for Iowa medical doctors (MDs) and doctors of osteopathic medicine (DOs). 
"The IMS membership consisted of 4,700 physicians as of Augus~ 31, 2003. To qualify for 
membership, a physician must have the appropriate medical education and hold an Iowa 
drivers license" (IMS, 2004, p. 6). The IMS 2004 Membership Directory also notes that 
most IMS members also belong to the national American Medical Association (AMA) and 
their county societies. 
Using the directory as the sampling frame, the names of all family and general 
practitioners were extracted, out of which 210 physicians were randomly selected to 
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comprise the sample. Physicians were selected randomly by picking every sixth physician in 
list using a random start. 
According to the Iowa Board of Medical Examiners (IBME), to practice medicine in 
Iowa, a license is required. The IBME regulates the practice of medicine and surgery, 
osteopathic medicine and surgery, osteopathy, and acupuncture in Iowa. According to the 
IBME (2004) website: 
To ensure that citizens of the state have access to safe care, the Board examines, 
licenses, and disciplines practitioners under its jurisdiction in accordance with state 
law and administrative rules. The Board is part of the Iowa Department of Public 
Health, although the board is not co-located with the department. (p. 1) 
The requirements to obtain a permanent license in the state oflowa are generally the same 
for DOs and MDs. Applicants must be at least 21 years of age and hold a medical degree 
from an educational institution approved by the board at the time the applicant graduated and 
was awarded the degree (Medical Examiners [653] ch.9, p.3). 
INSTRUMENT 
The self-administered questionnaire, divided into five main parts, contained a series 
of Likert-scale items intended to measure the tendency to write a prescription for a product 
advertised on television, physicians' responsiveness to patient requests that may result from 
exposure to television ads, physicians' attitudes towards television advertising of prescription 
drugs, and their report of the frequency with which patients inquire about or cite prescription 
products they see in televised advertisements. 
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The first section of the questionnaire measured the physicians' general attitudes 
toward television pharmaceutical advertising to consumers. This was operationalized by 
assessing physicians' perceptions of the adequacy of ad information, the extent to which they 
believe the television ads influence their patients, their evaluations of the extent to which 
their patients are confused by the ads, their assessments of how their patients find those ads 
credible, and the degree to which physicians comply with pharmaceutical company 
advertising. 
The second section of the questionnaire measures the doctors' observations of the 
:frequency with which patients inquire about or cite prescription drugs they saw in televised 
advertisements. This variable measures physicians' reports of how :frequently patients 
inquire about prescription products they have seen on television, patient requests for 
medications they have seen on television, and patient telephone and/or e-mail inquiries about 
drugs advertised on television to physicians' offices. 
The third portion of the questionnaire assesses the physicians' responsiveness to 
patient requests that may result from exposure to television ads for prescription products. 
This dependent variable was assessed by measuring the likelihood that physicians prescribe 
medications advertised on television that are appropriate for the patient's medical condition, 
the extent to which they believe that patients get better results if they are prescribed 
medications they have requested, the level of frustration they experience when patients 
request medications they have seen on television, and the likelihood that patients will discuss 
prescription options with physicians as a result of watching pharmaceutical advertisements 
on television. 
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Part four of the questionnaire is concerned with the tendency of physicians to write 
prescriptions for a product advertised on television. This was measured by determining 
whether physicians consider DTC television drug ads as a reminder to write prescriptions for 
products they like. The tendency of physicians to write prescriptions for drugs advertised to 
consumers via television was also assessed using Likert scale items. 
The fifth portion of the questionnaire investigates physicians' demographic 
characteristics, including their type of practice, practice specialty, where they hold their 
practice, medical degree, number of years in practice, gender, age, and the institution where 
their medical degree was obtained. 
PRE-TESTING 
As a pre-test, medical professionals employed at the Mercy Medical Center in Mason 
City, Iowa were asked to complete the questionnaire distributed to them by a registered 
nurse. The respondents were asked to indicate if the questions were properly worded and 
made sense to them. The respondents did not indicate any difficulty in answering the 
questions. 
RESEARCH QUESTIONS AND OPERATIONALIZATION OF VARIABLES 
The FDA uses the term "advertisement" to cover all kinds of information other than 
labels that promote a product. The term includes promotions broadcast on television or 
radio, conducted by telephone, or printed in magazines or newspapers" (Nordenberg, 1998). 
However, this study only examines prescription drug and/or product advertising exclusively 
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broadcast on television. In this study, DTC advertising will be defined as advertisements 
aired on television that promote prescription pharmaceutical products. 
Applying the tenets of the diffusion of innovations theory and the two-step flow 
hypothesis, this study aims to answer the following research questions and hypotheses: 
Hl: The physicians' attitudes toward televised DTC prescription product advertising 
influences their tendencies to prescribe products featured in such advertisements. 
Physicians' general attitudes toward DTC television advertising is conceptually 
defined as a physician's disposition regarding the advertising of prescription drugs to 
consumers. A physician's attitude is assessed through Likert-scale items that measure the 
degree to which the respondent agrees or disagrees with statements regarding (1) the 
adequacy of information provided to consumers via DTC television ads for prescription 
drugs, (2) the idea that prescription drugs should be directly advertised to patients, (3) the 
notion that such ads are confusing to their patients, ( 4) their sense of whether their patients 
are better informed as a result of DTC television drug ads, and ( 5) their stand about 
pharmaceutical companies advertising via television given that healthcare should not be 
about making a profit. 
Physicians' prescription writing tendency is defined as the likelihood that they will 
prescribe a prescription product advertised on television. This variable was measured using 
Likert-scale items that ask the degree to which the respondent agrees or disagrees with the 
following statements: (1) If a patient asks for a specific medication that is appropriate for 
that patient's medical condition as a result of watching a television ad, I am happy to write a 
prescription for that product, (2) My patients get better results if they are on medication they 
have requested, (3) I am frustrated by my patients' requests for medications they have seen 
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advertised on television and would not write a prescription they are asking for, ( 4) My 
patients are more likely to discuss prescription options as a result of watching pharmaceutical 
advertisements on television, ( 5) Pharmaceutical ads for prescriptions I see on television 
remind me to write prescriptions for products I like, (6) Televised pharmaceutical ads for 
prescription products that are appealing increase my tendency to write prescriptions for the 
advertised product, and (7) The advertisements I see for prescription products on television 
have no impact on what prescriptions I choose to write. 
RQl: How do physicians perceive the extent to which patients are exposed to DTC 
television ads promoting prescription products? 
Perceptions of the extent to which patients are exposed to DTC ads was assessed 
through the use of Likert-scale items that measure the extent to which they agree that (1) 
Patients I see and treat inquire about prescriptions they have seen advertised on television, 
(2) Patients request medications they have seen advertised on television, and (3) patients 
telephone and/or e-mail my office inquiring about drugs they have seen advertised on 
television. 
RQ2: Are physicians influenced by their patients' demands for prescription products 
advertised on television? 
This research question is concerned mostly with patients' influence on physicians' 
prescription-writing habits, measured by the extent to which they agree with the Likert-scale 
item: If a patient asks for a specific medication that is appropriate for that patient's condition 
as a result of watching a television ad, I am happy to write a prescription for that product. 
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RQ3: Do individual demographic variables have a bearing on physicians' attitudes 
toward televised DTC prescription product advertising? 
The demographic variables of interest here were called out of the Petroshius et al. 
study (1995). These are (1) the physician's type of practice, primary practice specialty, 
setting of the practice, his or her medical degree, how many years he/she has practiced 
medicine, gender, age, and where the physicians obtained their medical degree. 
To answer this research question, a number of hypotheses specific to each 
demographic variable was posed: 
H2: The type of practice influences a physician's attitude toward televised DTC 
advertising of prescription products. 
Type of practice refers to whether the physicians were involved in private or group 
practice. 
H3: The physicians' practice specialty has a bearing on their attitude toward televised 
DTC advertising of prescription products. 
Practice specialty is conceptually defined as the physicians' area of expertise such as 
general practice, family practice and others. 
H4: The setting of practice influences physicians' attitudes toward televised DTC 
advertising of prescription products. 
The setting of practice refers to where the physician practices medicine, whether they 
hold their practice in an urban, suburban or rural area. 
HS: The type of medical degree has a bearing on physicians' attitudes toward DTC 
television advertising of prescription products. 
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Medical degree refers to the type of medical training or whether the physicians are 
doctors of osteopathic medicine (DO) or a medical doctor (MD). 
H6: How long a physician has been practicing his/her profession has a bearing on 
his/her attitude regarding televised DTC advertising of prescription products. 
How long a physician has practiced was operationalized as the number of years a 
physician has practiced medicine. In this study, this was divided into three categories: less 
than 10 years, between 10 and 20 years, and more than 20 years. 
H7: Gender affects physicians' attitude toward televised DTC advertising of 
prescription products. 
HS: Age of physician influences attitude toward DTC advertising of prescription 
products. 
H9: The medical school where a physician received his or her medical degree has a 
bearing on his/her attitude regarding televised DTC advertising of prescription 
products. 
The institutions where the Iowa doctors received his/her medical degree include the 
University of Iowa, Des Moines University, and others. 
RQ4: Do individual demographic variables have a bearing on the tendency of 
physicians to write prescriptions for products that are featured in televised ads? 
This research question asks about the impact of the same variables listed above on 
physicians' tendencies to prescribe drugs featured in television ads. Like RQ3, this question 
inspires a number of hypotheses: 
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HlO: Practice specialty has a bearing on doctors' tendencies to write prescriptions for 
products featured in televised DTC ads. 
Hll: Practice specialty has a bearing on physicians' tendencies to write prescriptions 
for products featured in televised DTC ads. 
H12: The setting of practice has a bearing on tendencies to write prescriptions for 
products featured in televised DTC ads. 
H13: The medical degree a physician holds has a bearing on tendencies to write 
prescriptions for products featured in televised DTC ads. 
H14: How long a physician has been practicing his/her profession has a bearing on 
his/her tendency to write prescriptions for products featured in televised DTC ads. 
HlS: Gender influences behavioral tendencies of physicians to write prescriptions for 
products featured in televised DTC ads. 
H16: Age of physician influences tendencies to write prescriptions for products featured 
in televised DTC ads. 
Hl 7: The medical school where a physician received his or her degree has a bearing on 
his/her tendency to prescribe drugs featured in televised DTC ads. 
The study also hypothesized that: 
H18: Physicians' perceptions of the frequency with which their patients refer to 
television ads influence their tendency to prescribe drugs featured in the ads. 
The reliability of the attitude and behavior indexes was ascertained before the 
statistical tests were performed. 
44 
CHAPTER 4. FINDINGS 
The impact of medical innovations on patient-physician relationships has been a 
topic of concern for researchers. This study explores the influence ofDTC advertising of 
prescription products on television on how physicians treat their patients. In taking an 
incisive look at the impact of DTC television advertising and its role in the eventual adoption 
or use of prescription drugs, the study specifically seeks to answer the following questions 
and hypotheses: 
Hl: Physicians' general attitudes toward televised DTC prescription product 
advertising influences their tendencies to prescribe products featured in such 
advertisements. 
RQl: How do physicians perceive the extent to which patients are exposed to 
DTC television ads promoting prescription products? 
RQ2: Are physicians influenced by their patients' demands for prescription 
products advertised on television? 
RQ3: Do individual demographic variables have a bearing on physicians' 
attitudes in regard to televised DTC prescription product advertising? 
RQ4: Do individual demographic variables have a bearing on the tendencies of 
physicians to write prescriptions for products that are featured in televised ads? 
H2: Physicians' perceptions of the frequency with which their patients refer to 
television ads influence their tendency to prescribe drugs f ea tu red in the ads. 
Both patients and physicians can benefit from a better understanding of the dynamics 
of the patient-physician relationship. This study aims to assist pharmaceutical marketers in 
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gauging whether their advertising efforts reach their objectives. The results of the study 
should also help assess if DTC television advertising of prescription products serves both the 
promotional interests of the pharmaceutical industry as well as public health needs. 
THE SAMPLE 
The sample, consisting of 210 family or general practice physicians were randomly 
selected from the 2004 Iowa Medical Society directory of physicians licensed in Iowa. Of 
these, a total of 98 questionnaires were completed and returned. 
Twenty-one of the physician respondents were female; 76 were male. The ages of the 
respondents ranged from 31 to 85 years (mean= 50.95 years). Seventy-seven indicated they 
practice with MD degrees, while 19 were DOs. A little more than two-thirds (67) of the 
respondents indicated that they practice in a group setting, 18 practice in a private setting, 
and 12 indicated they practice in settings other than group or private. All but five are 
primarily family practitioners; three indicated their specialty as general practice. Only one 
respondent identified a different type of practice. 
At least half ( 49) of those who responded to the questionnaire indicated they have 
practiced medicine for more than 20 years. Twenty-eight of the respondents indicated they 
had practiced between ten and 20 years, and 20 had practiced less than ten years. 
A majority of the respondents (53) classified the setting of their practice as rural, 18 
as suburban, and 25 as urban. (See also Appendix E and F for a comparison of state and 
sample demographic characteristics.) 
Fifty-one respondents received their degrees from the University oflowa, 17 went to 
Des Moines University, while 28 were trained elsewhere. 
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As shown in Appendix E and F, the sample's demographic statistics match closely 
those of the states physician population. It can therefore be assumed that the study' s 
respondents are representative of the population of doctors in the state. 
DESCRIPTIVE STATISTICS 
Section I of the questionnaire included five questions that asked how physicians feel 
about television advertising of prescription products to consumers. The responses ranged 
from 1 =strongly agree, 2=slightly agree, 3=neither agree nor disagree, 4=slightly disagree, 
and 5 =strongly disagree. 
The first question asked whether physicians believed televised pharmaceutical 
advertising directed at consumers provided them with adequate information. The mean 
response to this question was 4.14 (std. dev. = 1.13), indicating they slightly disagree with 
this item. 
Question 2 asked if physicians felt pharmaceutical companies should not advertise to 
the public via television. The results indicate that physicians tend to agree with the idea that 
pharmaceutical companies should not advertise on television (mean= 1.85; std. dev. = 1.17). 
Question 3 asked physicians if they agreed that television advertisements promoting 
new drugs are confusing to their patients. Again, physicians indicated they felt the DTC ads 
for prescription products were confusing to their patients (mean= 1.71; std. dev. = .89). 
The fourth question asked the extent to which they agree that televised 
pharmaceutical advertising directed at consumers makes them better informed. The response 
(mean= 3.67; std. dev. = 1.13) was close to the middle of the scale. 
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The final question asked physicians to identify their level of agreement with the 
statement "I do not like the idea of pharmaceutical companies advertising via television 
because health care should not be about making a profit." Again, the response to this 
question appeared to indicate indifference, with a 3.01 average (std. dev. = 1.18). 
The second section of the questionnaire posed four questions concerning physicians' 
perceptions of the methods and frequencies with which patients refer to ads for prescription 
products they have seen on television. The response scales for the question again ranged 
from one to five ( 1 =hardly ever, 2=once in a while, 3=somewhat often, 4=often, 5=every 
day). 
Question one asked physicians to rate how often the patients they see and treat inquire 
about prescriptions they have seen advertised on television. It appears that patients tend to 
ask about advertised products at least once in a while to fairly often (mean= 2.88; std. dev. = 
.95). 
The second question had physicians rate how often patients request medications they 
have seen advertised on television. Again, it appears that patients do in fact request 
medications they have seen advertised once in a while (mean= 2.69; std. dev. = .95). 
Question three deals with the frequency with which patients telephone and/or e-mail 
their physicians' offices, inquiring about drugs they have seen advertised on television. 
Physicians' responses indicated that patients do not call or email their offices often. The 
mean average response was 1.95 (std. dev. = .93), meaning that patients do so only once in a 
while. 
How physicians respond to patient requests was the theme of the four questions posed 
in Section III of the questionnaire. 
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Question one asked physicians to indicate how much they agree with the statement, 
"If a patient asks for a specific medication that is appropriate for that patient's condition as a 
result of watching a television ad, I am happy to write a prescription for that product." The 
mean response of2.64 (std. dev. = 1.15) indicated that physicians were between neutral and 
slightly agree with the statement. 
The second question asked whether physicians felt that their patients get better results 
if they are on medication they have requested. The responses were neutral (mean= 3.28; std. 
dev. = 1.12) on this scale. 
Question three asked physicians to indicate their level of agreement with the 
statement, "I am frustrated by requests from my patients for medications they have seen 
advertised on television and would not write a prescription they are asking for." Physicians' 
responses did not indicate a high level of frustration on their part. The mean, 3 .4 7 (std. dev. 
= 1.10), was somewhere between neither disagree or agree and slightly disagree. 
The higher likelihood of patients discussing prescription options with physicians as a 
result of watching television ads was the theme of question four in the third section. A 2.73 
mean response (std. dev. = 1. 03) indicated that physicians were leaning toward indifferent 
feelings regarding the question. 
Section N of the questionnaire sought to explore whether such DTC drug ads on 
television influence the work of physicians. 
Physician responses to question one indicated that they slightly disagree with the idea 
that pharmaceutical ads for prescription products they see on television remind them to write 
prescriptions for products they like (mean= 4.24; std. dev. = .91). 
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Question two asks if physicians feel that televised pharmaceutical ads for prescription 
products that are appealing increase their tendency to write prescriptions for the product 
being advertised. Similar to question two of this section, it appears that doctors slightly 
disagree with this idea, as the average mean response registered at 4.20 (std. dev. = 1.03). 
The final question in section IV asked if physicians agreed with the statement that the 
advertisements they see on television for prescription products have no impact on what 
prescriptions they choose to write. A mean average response of 2.02 (std. dev. = 1.21) 
indicated that the physicians slightly agreed with this statement. 
In sum, the descriptive statistics indicate a number of important conclusions regarding 
the perceptions of physicians in relation to the DTC advertising of prescription drugs on 
television. Most notably, physicians felt that ads on television for pharmaceutical products 
did not provide adequate information to consumers. For the most part, physicians agreed 
with the idea that pharmaceutical companies should not advertise prescription products to the 
general public. Physicians also slightly agree that DTC television ads for prescription 
products confuse their patients. 
The response statistics also clearly point out that physicians do not feel that television 
ads for drugs they like remind them to write prescriptions for those products. There is a 
considerable consensus among physicians that they did not believe they are unlikely to write 
prescriptions for products advertised on television. 
RESEARCH QUESTIONS AND HYPOTHESES 
Hl: Physicians' attitudes toward televised DTC prescription product advertising 
influence their tendencies to prescribe products featured in such advertisements. 
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To determine ifthere is a relationship between physicians' attitudes toward DTC television 
advertising of prescription drugs and their tendencies to prescribe products featured in 
television ads, two indices were computed: one that measures attitudes and another that 
measures prescription writing tendencies. 
The computed attitude index consisted of five variables measured using the following 
five Likert scale items whose responses range from 1 (strongly disagree) to 5 (strongly 
agree). 
I 1. Televised pharmaceutical advertising directed to consumers provides them with 
adequate information. 
I 2. Pharmaceutical companies should not advertise to the general public via 
television. 
I 3. The television advertisements that promote new drugs to my patients are 
confusing to them. 
I 4. Televised pharmaceutical advertising directed toward consumers makes their 
patients better informed. 
I 5. They do not like the idea of pharmaceutical companies advertising via television 
because health care should not be about making a profit. 
Their responses to these items were summed to form the attitude index. A reliability test of 
the items comprising the index produced an alpha= .68. 
To measure prescription-writing tendencies, another index composed ofresponses to 
six items was calculated. The variables comprising this index assessed the extent to which 
the physicians agree that: 
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III 1. They are happy to write a prescription if a patient asks for a specific medication 
that is appropriate for that patient's condition as a result of watching a television ad. 
III 2. Their patients get better results if they are on medication they have requested. 
III 3. They are frustrated by requests from my patients for medication they have seen 
advertised on television and would not write a prescription they are asking for. 
III 4. Their patients are niore likely to discuss prescription options as a result of 
watching pharmaceutical advertisements on television. 
IV 1. Pharmaceutical ads for prescription drugs they see on television remind them to 
write prescriptions for products they like. 
N 2. Televised pharmaceutical ads for prescription products that are appealing 
increase their tendency to write prescriptions for the advertised product. 
IV 3. The advertisements physicians see for prescription products on television have 
no impact on what prescriptions they choose to write. 
A reliability test of the items comprising the index produced an alpha= .54. 
Using the indices, a Pearson correlation test was conducted. The results in Table 2 
(r = .51; p ~ .001) show that there is a relationship between physicians' attitudes in 
regard to DTC prescription product advertising on television and their tendencies to prescribe 
products featured in those ads. This relationship was also found to be very highly significant. 
' 
The positive correlation indicates that as physicians' attitudes in relation to DTC television 
advertising of prescription drugs improve, they are more likely to prescribe the featured 
drugs. 
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Table 2. Pearson correlation testing the relationship between physicians' attitudes 
toward DTC ads and their tendency to prescribe the advertised products 
Tendency to prescribe 
ATTITUDE the advertised products 
Pearson Correlation 1 .509* 
Sig. (2-tailed) .000 
N 95 88 
A simple linear regression test was conducted next to determine causality. That is, 
does attitude lead to behavior? The results of the regression test showed that the attitudes of 
physicians do affect their tendency to prescribe products featured in the televised ads. Again, 
this was found to be very highly significant (F = 30.12; p < .001). According to the statistical 
findings (Table 2), about 26 percent of the variance in prescription-writing behavior is 
explained by the doctors' attitudes toward the television ads. 
Table 3. Linear regression model summary between attitude and tendency to prescribe 
the advertised products 
Model R RSquare Adjusted R Std. Error of 
Square the Estimate 
1 .509a .259 .251 3.32093 
a. Predictors: (Constant), ATTITUDE 
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Table 3. Cont'd. 
ANOVA 
Model Sum of df Mean F Sig. 
Squares Square 
1 Regression 332.167 1 332.167 30.119 .oooa 
Residual 948.458 86 11.029 
Total 1280.625 87 
a. Predictors: (Constant), ATTITUDE 
b. Dependent Variabl"e: PRESCRIB 
Therefore, Hypothesis 1 is supported. The data show that there is a very strong 
relationship between attitudes of physicians in regard to DTC television prescription product 
advertising and the likelihood that they will prescribe the products featured in the ads. The 
results also show causality. That is, physicians' attitudes have a direct bearing on their 
prescription-writing behavior. 
RQl: How do physicians perceive the extent to which their patients are exposed 
to DTC television ads promoting prescription products? 
On average, the physicians indicated that the patients they see and treat do inquire 
about products they have seen advertised on television once in a while, and nearly somewhat 
often (mean= 2.88; std. dev. = .95). They also noted that their patients also request 
prescriptions they have seen advertised on television at least once in a while. Patients were 
also said to telephone and/or e-mail physicians' offices, inquiring about drugs they have seen 
advertised on television once in a while (mean= 2.69; std. dev. = .95). 
Overall, it appears that the physicians think that their patients are being exposed to 
DTC advertising fairly often. They report that their patients ask about specific products, 
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request products they have seen advertised, or call or e-mail their offices inquiring about the 
products fairly often. 
RQ2: Are physicians influenced by their patients' demands for such products? 
The results show that physicians are responding to their patients' demands for 
prescription products on television only in some instances. The respondents indicated slight 
agreement with the statement, "If a patient asks for a specific medication that is appropriate 
for that patient's condition as a result of watching a television ad, I am happy to write a 
prescription for that product" (mean= 2.64; std. dev. = 1.15). 
Research questions 3 and 4 seek to discover whether demographic variables have an 
impact on attitudes and prescription-writing behavior. 
RQ3: Do individual demographic variables have a bearing on physicians' 
attitudes toward televised DTC prescription product advertising? 
Eight hypotheses were posed to answer this question. 
H2: The type of practice influences a physicians' attitude toward televised DTC 
advertising of prescription products. 
A one-way ANOV A was performed to determine ifthere are differences among types of 
practice in terms of attitudes. The testing (Table 4) revealed no significant differences 
among groups in terms of attitudes toward televised prescription ads and type of practice. No 
significant differences in attitudes exist by type of practice or whether the physicians practice 
in a group or privately. This hypothesis was therefore not supported. 
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Table 4. ANOV A testing for differences in attitude by type of practice 
Sum of df Mean F Sig. 
Squares Square 
Between Groups 1.584 2 .792 .060 .942 
Within Groups 1206.384 91 13.257 
Total 1207.968 93 
H3: Physicians' area of specialization has a bearing on their attitude toward 
televised DTC advertising of prescription products. 
A one-way ANOVA was conducted to test this hypothesis. The results (Table 5) show no 
statistically significant difference among family, general and other practitioners in their 
attitude toward DTC drug advertising (F = .37; p = .69). The results, therefore, did not 
support the hypothesis. 
Table 5. ANOV A testing for differences in attitudes by practice specialty 
Sum of df Mean F Sig. 
Squares Square 
Between Groups 9.682 2 4.841 .368 .693 
Within Groups 1198.286 91 13.168 
Total 1207.968 93 
H4: The setting of practice influences physicians' attitudes toward televised DTC 
advertising of prescription products. 
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Again, a one-way ANOVA was done to test this hypothesis. The results (Table 6) show that 
physicians practicing in urban, suburban or rural settings did not differ in their attitudes 
toward DTC advertising (F = .084; p = .92). Therefore, this hypothesis was not supported. 
Table 6. ANOV A testing for differences in attitudes by practice setting 
Sum of df Mean F Sig. 
Squares Square 
Between Groups 2.249 2 1.124 .084 .920 
Within Groups 1205.579 90 13.395 
Total 1207.828 92 
HS: The type of medical degree has a bearing on physicians' attitudes toward 
DTC television advertising of prescription products. 
The type of medical degree held by a physician was not shown to have any bearing on their 
attitudes toward DTC television advertising of prescription products. The one-way ANOV A 
(Table 7) done to test this hypothesis produced an F of 1.49 (p = .23). The results, therefore, 
did not support the hypothesis. 
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Table 7. ANOVA testing for differences in attitudes by medical degree 
Sum of df Mean F Sig. 
Squares Square 
Between Groups 19.203 1 19.203 1.487 .226 
Within Groups 1175.464 91 12.917 
Total 1194.667 92 
HS: How long a physician has been practicing his/her profession has a bearing 
on his/her attitude regarding televised DTC advertising of prescription products. 
A one-way ANOV A was performed to ascertain if significant differences exist among 
physicians regarding their attitudes depending on how long they have practiced medicine 
(Table 8). The results (Table 8) show that years in practice, categorized into less than 10 
years, between 10 and 20 years, or more than 20 years, has no significant influence on 
attitudes (F = 1.26; p = .29). The hypothesis was therefore not supported. 
Table 8. ANOV A testing for differences in attitudes by years in practice 
Sum of df Mean F Sig. 
Squares Square 
Between Groups 19.203 1 19.203 1.487 .226 
Within Groups 1175.464 91 12.917 
Total 1194.667 92 
H7: Gender affects physicians' attitude toward televised DTC advertising of 
prescription products. 
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At-test was conducted to test this hypothesis (Table 9). The results show that males and 
females do not differ in their attitudes (t = .63; p = .531). The hypothesis was therefore not 
supported. 
Table 9. Independent samples t-test testing differences in attitudes between male and 
female physicians 
Std. Error 
Gender of physician N Mean Std. Deviation Mean 
Female 21 10.1905 3.80288 .82986 
Male 73 10.7534 3.56207 .41691 
t-test for Equality of Means 
t df Sig. Mean 
(2-tailed) Difference 
Equal variances assumed -.629 92 .531 -.5629 
Equal variances not -.606 30.824 .549 -.5629 
Assumed 
HS: Age influences physicians' attitudes toward DTC advertising of 
prescription products. 
A Pearson correlation test (Table 10) conducted to test this hypothesis showed a very weak 
positive relationship between age and attitude of physicians (r = .036; p = .73). Age, 
therefore, is not related to physicians' attitudes. The hypothesis was therefore not supported. 
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Table 10. Pearson correlation testing the relationship between attitude and age 
ATTITUDE PRESCRIBE 
Pearson Correlation 1 .036 
Sig. (2-tailed) . .731 
N 95 94 
H9: The medical school where a physician received his or her medical degree 
has a bearing on his/her attitude regarding televised DTC advertising of 
prescription products. 
A one-way ANOVA done to test this hypothesis (Table 11) indicated no attitudinal 
differences among physicians based on where they received their medical education (F = .74; 
p = .48). The hypothesis was therefore not supported. 
Table 11. ANOVA testing for differences in attitudes by medical education 
Sum of df Mean F Sig. 
Squares Square 
Between Groups 19.577 2 9.789 .743 .479 
Within Groups 1185.713 90 13.175 
Total 1205.290 92 
The statistical tests conducted did not produce significant findings. Therefore one 
can conclude that demographic variables have no effect on the physicians' attitudes toward 
televised advertising of prescription products. The next research question looks at the impact 
of the same demographic variables on physicians' tendency to prescribe advertised products. 
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RQ4: Do individual demographic variables have a bearing on the tendency of 
physicians to write prescriptions for products that are featured in televised ads? 
The same tests were conducted to determine the variables that have an impact on 
physicians' tendencies to write prescriptions for products featured in televised ads. 
HlO: The type of practice has a bearing on physicians' tendencies to write 
prescriptions for products featured in televised DTC ads. 
The results of a one-way ANOV A used to test this hypothesis show no statistically 
significant group differences in prescription-writing tendencies (Table 12). That is, 
prescription-writing behaviors do not differ by type of practice (group or private). This 
hypothesis was therefore not supported (F = .070; p = .93). 
Table 12. ANOV A testing for differences in prescription-writing tendencies by type of 
practice 
Sum of df Mean F Sig. 
Squares Square 
Between Groups 2.076 2 1.038 .070 .933 
Within Groups 1278.688 86 14.868 
Total 1280.764 88 
H11: Physicians' area of specialization has a bearing on their tendencies to write 
prescriptions for products featured in televised DTC ads. 
The physicians' prescription-writing behaviors did not differ by specialty as shown by the 
results of a one.,way ANOV A (Table 13). The results showed no statistically significant 
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differences among family and general practitioners (F = .019; p = .98) in their tendencies to 
prescribe the advertised product. Therefore, this hypothesis was not supported. 
Table 13. ANOV A testing for differences in prescription-writing tendencies by practice 
specialty 
Sum of df Mean F Sig. 
Squares Square 
Between Groups .576 2 .288 .019 .981 
Within Groups 1280.188 86 14.886 
Total 1280.764 88 
H12: The setting of practice has a bearing on tendencies to write prescriptions 
for products featured in televised DTC ads. 
Differences in prescription-writing behaviors among physicians in urban, suburban, and rural 
settings were not found to exist. The one-way ANOVA test (Table 14) did not show 
statistically significant differences among the groups (F = 1.04; p = .36) in terms of 
prescription-writing tendencies. The hypothesis was therefore not supported. 
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Table 14. ANOV A testing for differences in prescription-writing tendencies by the 
location of practice 
Sum of df Mean F Sig. 
Squares Square 
Between Groups 30.460 2 15.230 1.041 .357 
Within Groups 1243.313 85 14.627 
Total 1273.773 87 
H13: The medical degree a physician holds has a bearing on tendencies to write 
prescriptions for products featured in televised DTC ads. 
A one-way ANOV A done to test this hypothesis (Table 15) revealed no significant 
differences in prescription-writing behavior based on the type of medical degree a physician 
holds (F = .38; p = .54). 
Table 15. ANOVA testing for differences in prescription-writing tendencies by medical 
degree 
Sum of df Mean F Sig. 
Squares Square 
Between Groups 30.460 2 15.230 1.041 .357 
Within Groups 1243.313 85 14.627 
Total 1273.773 87 
63 
H14: How long a physician has been practicing his/her profession has a bearing 
on his/her tendency to write prescriptions for products featured in televised 
DTC ads. 
A one-way ANOVA produced results that did not support this hypothesis (Table 16). There 
was no statistically significant differences in prescription-writing tendencies based on the 
number of years the physicians have spent practicing medicine (F = .38; p = .69). 
Table 16. ANOVA testing for differences in prescription-writing tendencies by years in 
practice 
Sum of df Mean F Sig. 
Squares Square 
Between Groups 11.228 2 5.614 .380 .685 
Within Groups 1269.536 86 14.762 
Total 1280.764 88 
H15: Gender influences the tendencies of physicians to write prescriptions for 
products featured in televised DTC ads. 
At-test was conducted to determine whether males and females differ in their prescription-
writing tendencies (Table 17). The t-test revealed no significant differences between the two 
groups (t = 1.105; p = .272). Therefore, this hypothesis was not supported. 
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Table 17. Independent samples t-test testing gender differences in prescription-writing 
tendencies 
Std. Error 
Gender of physician N Mean Std. Deviation Mean 
Female 20 19.2000 4.22524 .94479 
Male 69 18.1304 3.68588 .44373 
t-test for Equality of Means 
t df Sig. Mean 
(2- Difference 
tailed) 
Equal variances assumed 1.105 87 .272 1.0696 
Equal variances not assumed 1.025 27.927 .314 1.0696 
Hl 6: Age of a physician influences his/her tendencies to write prescriptions for 
products featured in televised DTC ads. 
A Pearson correlation test was performed to determine whether a significant relationship 
exists between a physician's age and his/her prescription-writing habits (Table 18). While a 
significant relationship was not found, a weak negative correlation was uncovered (r = -.12; p 
= .27); indicating that older doctors have a very slight tendency to prescribe products 
featured in DTC television ads less. Therefore, this hypothesis was not supported. 
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Table 18. Pearson correlation testing the relationship between prescription-writing 
tendencies 
ATTITUDE PRESCRIBE 
Pearson Correlation 1 -.119 
Sig. (2-tailed) .266 
N 89 89 
Hl 7: The medical school where a physician received his or her medical degree 
has a bearing on his/her tendency to prescribe drugs featured in televised DTC 
ads. 
The results of a one-way ANOV A (Table 19) show that the physicians' prescription-writing 
tendencies have nothing to do with where they obtained their medical degrees (F = .74; p = 
.48). Therefore, the hypothesis was not supported. 
Table 19. ANOV A testing for differences in prescription-writing tendencies by 
institution of medical training 
Sum of df Mean F Sig. 
Squares Square 
Between Groups 21.518 2 10.759 .735 .483 
Within Groups 1259.246 86 14.642 
Total 1280.764 88 
Hl 7: Physicians' perceptions of the frequency with which their patients refer to 
television ads influence their tendency to prescribe drugs f ea tu red in the ads. 
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To test this hypothesis, a Pearson correlation test was performed. While a statistically 
significant correlation was not found to exist between how often physicians observed their 
patients to refer to products advertised on television and their tendency to prescribe those 
products (Table 20), a weak negative correlation was found (r = -.1 O; p = .342). This 
negative correlation implies that the more physicians perceive their patients as referring to 
television ads promoting prescription products, they have a slightly increased tendency to 
prescribe the products featured in those ads less. This hypothesis was therefore not 
supported. 
· Table 20. Pearson correlation testing for the relationship between tendency to prescribe 
products featured in those ads and perceived frequency of patients' inquiries 
Frequency of Tendency to prescribe 
patient inquiry advertised products 
Pearson Correlation 1 -.102 
Sig. (2-tailed) . .342 
N 96 88 
SUMMARY OF FINDINGS 
The results of this study revealed that physicians' attitudes toward televised DTC 
prescription product advertising does have an impact on their tendencies to write 
prescriptions for the drugs featured in such ads. Furthermore, results of a linear regression 
test indicated that attitudes of physicians do in fact affect their tendencies to prescribe 
products featured in ads. 
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The physician respondents indicated that their patients inquire about products they 
have seen advertised at least "once in a while" to "somewhat often." They also report that 
their patients requested prescription products advertised on television at least "once in a 
while." Patients were also said to telephone and/or email their physicians' offices inquiring 
about drugs they have seen advertised "once in a while." 
Were the physicians influenced by their patients' demands for such products? The 
findings indicate that patients hold influence regarding their treatment. Physicians slightly 
agreed that they are happy to write prescriptions for products advertised on television that are 
requested by patients when that particular drug is appropriate for that patient's condition. 
As probable antecedents, the type of practice, practice specialty, setting of practice, 
type of medical degree, years in practice, gender, age, and where the medical degree was 
obtained were tested for their influence on physicians' attitudes toward DTC advertising and 
their tendency to prescribe the products featured in the ads. Overall, these demographic 
variables were not found to have any bearing on physicians' attitudes and their prescription-
writing tendencies. The findings of this study are substantially different from that of 
Petroshius et al. (1995) who found that physicians' attitudes toward the advertising of 
pharmaceuticals were favorable, and that significant differences in attitudes were found 
among various physician sub-groups. On the other hand, the findings of this study tended to 
indicate that physicians are not entirely favorable to televised DTC advertising of 
prescription products. Their responses indicated that they slightly agree with the statement 
that pharmaceutical companies should not be advertised to the general public via television. 
The Petroshius et al. (1995) concluded that: 
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In general, older physicians, those in practice more than 20 years, and internists are 
less favorable toward pharmaceutical advertising and cosmetic pharmaceuticals and 
report being less attentive to and influenced by advertising as well as patient requests. 
Some differences were also revealed with respect to the type of practice the physician 
was in (group versus private) as well as setting of the practice (urban/suburban versus 
rural). (p. 45) 
On the contrary, this study, found no statistically significant differences caused by any 
demographic variables. 
The findings of Petroshius et al. with respect to the relationship between physicians' 
attitudes and their tendency to prescribe products featured in televised advertising were 
replicated. The results from the Petroshius et al. study (1995) indicate that pharmaceutical 
advertising's influence on physicians' prescription-writing habits can be explained partially 
by physicians' attitudes toward the advertising of pharmaceuticals to physicians (B = .421; p 
< .000) and by their attitudes toward the advertising of cosmetic pharmaceuticals (B = .268; p 
< .000). This study also found a highly significant relationship between attitudes of 
physicians and their tendencies to prescribe products (r = .51; p ~ .001) featured in DTC 
television ads. 
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CHAPTER 5. DISCUSSION AND CONCLUSIONS 
This study examined the impact of televised direct-to-consumer prescription product 
advertising on physicians' attitudes toward such advertising and their prescription-writing 
tendencies in relation to the products featured in such ads. Research questions were posed to 
investigate physicians' attitudes towards televised DTC advertising, how often physicians 
perceived their patients to cite products featured in the ads, whether they write prescriptions 
for the products featured in DTC ads, and if physician attitudes differ by demographic 
variables. 
As such, this study explored an aspect of the communication relationship between 
physicians and their patients and how this relationship may have been affected by 
advertisements for drugs that now directly target the consumers rather than their doctors. 
In doing so, the study looked at whether pharmaceutical marketers' promotional 
efforts are influencing the innovation-decision processes of physicians who prescribe those 
drugs. The results of the study are also meant to help assess ifDTC television advertising of 
prescription products serves both the promotional interest of the pharmaceutical industry as 
well as public health needs. 
THE CURRENT STUDY VERSUS THE PETROSHIUS ET AL. STUDY (1995) 
The findings of this study vary dramatically in some respects from the results of the 
Petroshius et al. (1995) study, which inspired it. 
Petroshius et al. (1995) found, for example, that physicians for the most part were 
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favorable toward DTC advertising. The current study found otherwise - physicians were not 
favorable to DTC advertising on television. 
A number of factors could account for the differences in attitudes of physicians in the 
two studies. First, the current study is limited to Iowa practitioners, whereas the Petroshius et 
al. study (1995) was administered to physicians in three states: Ohio, Michigan, and Indiana. 
The two studies were obviously conducted at two different periods in the diffusion of drng 
information through television. When Petroshius et al. conducted their study in 1995, DTC 
television advertising had just began. It can therefore be assumed that very few DTC ads 
were aired on television at that time. Could it be that physicians' attitudes regarding such 
advertising have changed as DTC advertising on television has become more pervasive? It is 
also important to note that the current study focuses specifically on televised DTC ads of 
prescription products, whereas the Petroshius et al. (1995) study does not single out a specific 
form of DTC advertising. Could this indicate that physicians feel differently about different 
forms of DTC advertising? Are physicians more opposed to advertising via television versus 
print or other media outlets? 
In the two studies, strong attitude-behavior relationships were reported. Petroshius et 
al. states: "In general, the findings suggest that physicians' attitudes toward pharmaceutical 
advertising are good predictors of which physicians are most likely to attend to such ads and 
likely be responsive to patient inquiries and requests for advertised pharmaceuticals" (p. 47). 
They added that "the strong attitude-behavior relationships reported here may be indicative 
of the high degree of [patient] involvement in the physician's prescription [writing] process. 
This is consistent with past research that suggests that attitudes better predict behavior under 
high involvement conditions" (p. 47). The fact that strong attitude-behavior relationships 
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resulted from both studies further supports their concept of a high degree of patient 
involvement in the prescription-writing process. 
In the two-step flow of communication hypothesis, which resulted from diffusion of 
innovations research, the role of interpersonal influence on behavior is key. The studies that 
produce these results, however, have attempted different ways to account for the impact of 
interpersonal relations in their research designs. 
The findings of this study support the two-step flow hypothesis in that it consistently 
found that physicians' attitude is directly linked and is an important contributor to their 
tendencies to prescribe a product their patients learned from ads they saw on television. 
TWO-STEP FLOW AND INTERPERSONAL COMMUNICATION 
About the role of interpersonal communications in the decision-making process, Katz 
(1957) concluded: "Thus interpersonal relations are (1) channels of information, (2) sources 
of social pressure, and (3) sources of social support, and each relates interpersonal relations 
to decision-making in a somewhat different way" (p. 77). 
The results of the current study indicate conclusively that pharmaceutical products in 
DTC ads are often the subject of interpersonal conversations between physicians and 
patients. The doctors surveyed point out that their patients were referring to the ads and 
inquiring about the products they saw on television. To further bolster the finding that Iowa 
physicians do not favor the advertised products, a negative correlation was found between the 
frequency with which patients cite the ads they have viewed and the doctors' tendency to 
prescribe the products featured in those ads. It is clear, therefore, that physicians are 
uncomfortable when their patients ask for the advertised products during their interpersonal 
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encounters. Iowa physicians resoundingly agree that they do not wish their patients' 
inquiries about he advertised products during consultations to affect their decision about 
which treatment to prescribe. 
Despite the negative relationship found between the frequency with which physicians 
judge their patients as referring to ads and their tendencies to prescribe products featured in 
those ads, a strong positive correlation was found between their attitude and their 
prescription-writing tendencies. 
The results indicate that physicians see their patients as actively taking part in their 
treatments by inquiring about products they see in television ads. Although the physicians do 
not favor DTC advertising, their discussion with patients still influences their prescribing 
behaviors. It is clear, therefore, that interpersonal relations with patients is a legitimate 
additional stage in the diffusion process. 
The results of the current study indicate that interpersonal relations influence how 
physicians decide which drugs to prescribe. The Columbia drug study' s locus of diffusion 
model was developed to describe the diffusion of a new drug throughout a medical 
community. The findings of this study show that interpersonal relations with patients could 
be included as a sixth step in the locus of diffusion model developed by Coleman et al. in 
1966. In investigating the channels of information physicians today turn to when making a 
decision about which drug to prescribe, would doctors identify patients as a source to 
consider in some cases? 
The results of the study provide evidence to support the contention that the flow of 
information follows a two-step process: (1) from ads to patients and (2) from patients to 
doctors. As such, it appears that interpersonal communications with patients may not 
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necessarily be the deciding factor in determining which drug to prescribe, but it may be one 
of the factors. Thus, the flow of information beginning with the 
DTC ads-) Patients/Consumers-) Physicians has been supported by the study's findings. 
SUGGESTIONS FOR FUTURE STUDY 
The cost of prescription products is projected to continue to climb in the coming 
years. So too is the frequency that ads featuring them will be aired. Further study is 
therefore needed to learn more about the impact of this type of advertising on how doctors 
treat their patients. 
This study only looked at the physicians' perspective. Future studies should assess of 
both patients and physicians. 
Future efforts could also attempt to elaborate on the hypothesis that interpersonal 
relations between patients and physicians directly affect what physicians decide to prescribe. 
This field of inquiry will also benefit from a replication of taking into account the new 
consumers who are more aware of their drug options as a result of aggressive advertising. 
It should be noted that the findings of this study can only be generalized to physicians 
in Iowa who are members of the Iowa Medical Society, this study's state-based sample. A 
study using a national sample will be more able to produce more generalizable results. 
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APPENDIX A. METHOD OF INFORMED CONSENT 
March 5, 2004 
Dear Sir or Madam: 
My name is Jocelyn Albertson and I am a graduate student enrolled in the Greenlee School of 
Journalism and Mass Communication at Iowa State University in Ames, Iowa. In pursuit of my 
Master of Science degree, I am in the process of gathering data for my thesis, which explores the 
impact of direct-to-consumer advertising of prescription drugs. 
As a practicing physician, your response to the enclosed questionnaire can help provide information 
in a relatively new area of research that hopes to enhance the quality of pharmaceutical information 
made available to doctors and patients. 
Enclosed is a copy of the questionnaire. I would appreciate it if you would take ten minutes to 
complete it. Please note that completion of the questionnaire is voluntary in nature and the right to 
withdraw from the study is reserved. The sole purpose of the study is for research purposes only. 
Only my academic advisor and myself will have access to the returned questionnaires. 
Questionnaires will be destroyed once data analysis has been successfully completed. It will be very 
helpful if your completed questionnaire could be returned to me by March 16th. 
You will note that the questionnaire has a number located in the upper left-hand side. The purpose of 
. the number is just to help me track who has responded in the first wave of mailing. The 
confidentiality of your responses is guaranteed. If you need any additional information, please phone 
me at (515) 222-0297, or email me at albertso@iastate.edu. If you have any questions about the 
rights ofresearch subjects or research-related injury, please contact the Human Subjects Research 
Office, 2810 Beardshear Hall, (515) 294-4566; austingr@iastate.edu or the Research Compliance 
Officer, Office of Research Compliance, 2810 Beardshear Hall, (515) 294-3115; dament@iastate.edu. 
A stamped envelope is enclosed for your convenience. I sincerely appreciate your support and thank 
you in advance for your response. 
Sincerely, 
Jocelyn K. Albertson 
Greenlee School of Journalism and Mass Communication 
Iowa State University 
Cc: Lulu Rodriguez, Academic Advisor, (515) 294-0484 
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APPENDIX B. QUESTIONNAIRE COVER LETTER 
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APPENDIX C. QUESTIONNAIRE 
Please circle the option that most accurately describes your response to the 
questions below. 
I. How do you feel about television advertising of prescription 
products to consumers? 
1. Televised pharmaceutical advertising directed to consumers provides them with adequate 
information. 
Strongly 
agree 
Slightly 
agree 
Neither agree 
nor disagree 
Slightly 
disagree 
Strongly 
disagree 
2. I think pharmaceutical companies should not advertise to the general public via television 
commercials. 
Strongly 
agree 
Slightly 
agree 
Neither agree 
nor disagree 
Slightly 
disagree 
Strongly 
disagree 
3. The television advertisements that promote new drugs to my patients are confusing to 
them. 
Strongly 
agree 
Slightly 
agree 
Neither agree 
nor disagree 
Slightly 
disagree 
Strongly 
disagree 
4. Televised pharmaceutical advertising directed toward consumers makes my patients 
better informed. 
Strongly 
agree 
Slightly 
agree 
Neither agree 
nor disagree 
Slightly 
disagree 
Strongly 
disagree 
5. I do not like the idea of pharmaceutical companies advertising via television because 
health care should not be about making a profit. 
Strongly 
agree 
Slightly 
agree 
Neither agree 
nor disagree 
Slightly 
disagree 
Strongly 
disagree 
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II. Do your patients refer to television 
advertisements of prescription products? 
1. Patients I see and treat inquire about prescriptions they have seen advertised on 
television. 
Hardly 
ever 
Once in 
a while 
Somewhat 
often 
Often 
2. Patients request medications they have seen advertised on television. 
Hardly 
ever 
Once in 
a while 
Somewhat 
often 
Often 
Every 
day 
Every 
day 
3. Patients telephone and or email my office inquiring about drugs they have seen advertised 
on television. 
Hardly 
ever 
Once in 
a while 
Somewhat 
often 
III. How do you respond to patient requests? 
Often Every 
day 
1. If a patient asks for a specific medication that is appropriate for that patient's condition as 
a result of watching a television ad, I am happy to write a prescription for that product. 
Strongly 
agree 
Slightly 
agree 
Neither agree 
nor disagree 
Slightly 
disagree 
2. My patients get better results if they are on medication they have requested. 
Strongly 
agree 
Slightly 
agree 
Neither agree 
nor disagree 
Slightly 
disagree 
Strongly 
disagree 
Strongly 
disagree 
3. I am frustrated by requests from my patients for medications they have seen advertised on 
television and would not write a prescription they are asking for. 
Strongly 
agree 
Slightly 
agree 
Neither agree 
nor disagree 
Slightly 
disagree 
Strongly 
disagree 
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4. My patients are more likely to discuss prescription options as a result of watching 
pharmaceutical advertisements on television. 
Strongly 
agree 
Slightly 
agree 
Neither agree 
nor disagree 
Slightly 
disagree 
IV. Do these television ads influence your work? 
Strongly 
disagree 
1. Pharmaceutical ads for prescription drugs that I see on television remind me to write 
prescriptions for products I like. 
Strongly 
agree 
Slightly 
agree 
Neither agree 
nor disagree 
Slightly 
disagree 
Strongly 
disagree 
2. Televised pharmaceutical ads for prescription products that are appealing increase my 
tendency to write prescriptions for the advertised product. 
Strongly 
agree 
Slightly 
agree 
Neither agree 
nor disagree 
Slightly 
disagree 
Strongly 
disagree 
3. The advertisements I see for prescription products on television have no impact on what 
prescriptions I choose to write. 
Strongly 
agree 
Slightly 
agree 
Neither agree 
nor disagree 
V. Tell us a little about yourself ... 
1. What type of practice do you operate under? 
[1] Private 
[2] Group 
[3] Other (please specify) __________ _ 
2. What is your primary practice specialty? 
[1] General 
[2] Family practice 
[3] Other (please specify) __________ _ 
Slightly 
disagree 
Strongly 
disagree 
3. What is the setting of your practice? 
[1] Urban 
[2] Suburban 
[3] Rural 
4. Which medical degree do you hold? 
[1] Doctor of Medicine (MD) 
[2] Doctor of Osteopathic Medicine (DO) 
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[3] Other (please specify) ___________ _ 
5. For how many years have you practiced? 
[ 1] Less than 10 years 
[2] Between 10 and 20 years 
[3] More than 20 years 
6. What is your gender? 
[1] Female [2] Male 
7. What was your age on your last birthday? 
_____ years? 
8. Where did you receive your medical education? 
[ 1] University of Iowa 
[2] Des Moines University 
[3] Other (please specify) ___________________ _ 
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APPENDIX D. CODEBOOK 
DTC Television Prescription Drug Advertising 
Question Variables names and codes 
I. 
II. 
III. 
IV. 
v. 
1. 
2. 
1. 
2. 
3. 
4. 
5. 
1. 
2. 
3. 
1. 
2. 
3. 
4. 
1. 
2. 
3. 
[1] private 
[2] group 
[3] other 
[1] general 
Indentification 
INFO 
SHOULD 
CONFUSE 
INFORMED 
PROFIT 
INQUIRE 
REQUEST 
PHONEEMAIL 
ASKSPECIFIC 
RESULTS 
FRUSTRATED 
DISCUSS 
REMIND 
APPEAL 
NOIMPACT 
TYPE 
SPECIALTY 
[2] family practice 
[3] other 
3-digit number 
1 =strongly agree 
2=slightly agree 
3=neither agree nor disagree 
4=slightly disagree 
5=strongly disagree 
1 =hardly ever 
2=once in a while 
3=somewhat often 
4=often 
5=every day 
1 =strongly agree 
2=slightly agree 
3=neither agree nor disagree 
4=slightly disagree 
5=strongly disagree 
1 =strongly agree 
2=slightly agree 
3=neither agree nor disagree 
4=slightly disagree 
5=strongl y disagree 
1 =identified as type of practice 
2=not identified as type of practice 
1 =identified as specialty 
2=identified as specialty 
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3. SETTING 
[l] urban 1 =identified as setting 
[2] suburuban 2=identified as setting 
[3] rural 
4. MED DEGREE 
[l] MD 1 =identified as MD 
[2] DO 2=identified as DO 
[3] Other 3=idenitified as other 
5. YEARSPRAC 
[l] < 10 1 =identified as < 10 years in practice 
[2] 10-20 2=identified as 10-20 years in practice 
[3] > 20 3=identified as more than 20 years in practice 
6. GENDER 
[1] female 1 =identified as female 
[2] male 2=identified as male 
7. AGEINYEARS 2-digit number (number of years) 
8. MEDED 
[1] University oflowa 1 =identified as University of Iowa 
[2] Des Moines University 2=identified as Des Moines University 
[3] Other 3= identified as other 
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APPENDIX E. STATISTICS FOR CURRENTLY LICENSED 
PHYSICIANS IN IOWA 
At present, there are 5, 972 physicians licensed in the state of Iowa. Of those physicians, the 
IBME has the following statistical information: 
GENDER 
# O/o 
Gender 
Male 4,689 78.5 
Female 1,278 21.4 
MDv.DO 
# % 
Medical Degree 
5,026 84.2 
MD 
946 15.8 
DO 
Of the 5,972 licensed physicians in Iowa, 1,012 practice in either family or general practice, 
making up about 16.9% of the total number of physicians population in the state. Of the 
1,012 family and general practitioners, only two practice as general practitioners, and the 
remaining 1,010 are classified as family practitioners. 
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WHERE EDUCATION WAS OBTAINED 
# % 
Institution 
University of Iowa 1,895 31.7 
Des Moines University 705 11.8 
YEARS IN PRACTICE 
Years # O/o 
Under 10 2,388 40.0 
10-20 1,572 26.3 
Over 20 2,010 33.7 
AGES (for those who have dates of birth listed in applications) 
Years # O/o 
27-37 1,035 17.3 
38-50 2,378 39.8 
51 & over 2,556 42.8 
Source: G. Beebe, IBME (personal communication, April 26, 2004) 
*Note: Possessing a valid license to practice medicine in the state of Iowa does not 
necessarily indicate that the physician is actively practicing medicine. 
*Note: These are approximate figures. 
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APPENDIX F. SAMPLE STATISTICS 
Of the 210 physicians who were sent questionnaires, 98 physicians completed the survey. 
The demographic characteristics of this sample follows: 
GENDER 
# O/o 
Gender 
Male 76 77.6 
Female 21 21.6 
MDv.DO 
# O/o 
Medical Degree 
MD 77 78.6 
DO 19 19.4 
SETTING OF PRACTICE 
# O/o 
Setting 
Urban 25 25.5 
Suburban 48 18.4 
Rural 53 54.1 
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WHERE EDUCATION WAS OBTAINED 
# % 
Institution 
University of Iowa 51 52.0 
Des Moines University 17 17.3 
YEARS IN PRACTICE 
Years # O/o 
Under 10 20 20.4 
10-20 28 28.6 
Over 20 49 50.0 
AGES 
Years # O/o 
27-37 15 15.5 
38-50 38 39.2 
51 & over 44 45.4 
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APPENDIX G. PETROSHIUS ET AL. (1995) VARIABLES 
Influence of Pharmaceutical Ads on Prescription Drug Writing Habits 
+ Pharmaceutical ads remind me to write prescriptions for products I like. 
+ Pharmaceutical advertisements that are appealing increase my tendency to write prescriptions for the 
advertised product. 
+ The advertisements I see have no impact on what prescriptions I write. 
Responsiveness to Patient Requests 
+ If a patient asks for a specific, appropriate medication, I am happy to write a prescription for that product. 
+ My patients get better results if they are on medication that they requested. 
+ I am frustrated by requests from my patients for medication they've read about in advertisements and 
would not write the prescription they are asking for. 
Attention to Pharmaceutical Ads 
+ I don't pay much attention to pharmaceutical ads in my medical journals. 
Attitudes toward Pharmaceutical Advertising to Physicians 
+ Pharmaceutical advertisements give physicians useful information about products. 
+ Pharmaceutical advertisements give physicians honest information. 
+ Pharmaceutical advertising directed towards physicians is ethical. 
+ It is necessary for the FDA to have stricter guidelines concerning the advertisements that pharmaceutical 
companies place in medical journals. 
Attitudes toward Pharmaceutical Advertising to Consumers 
+ Pharmaceutical advertising directly to consumers provides them with accurate information. 
+ I think pharmaceutical companies should not advertise to the general public. 
+ The advertisements that promote new drugs to my patients are confusing to them. 
+ Pharmaceutical advertising directed toward consumers makes my patients happier and better informed. 
+ I do not like the idea of pharmaceutical companies advertising because health care should not be about 
making a profit. 
Attitudes toward Cosmetic Pharmaceuticals 
+ I am glad to see that pharmaceutical companies are developing more products associated with cosmetic 
conditions (i.e. aging skin, hair loss). 
+ In general, the new cosmetic pharmaceutical products are worthwhile for my patients. 
+ I do not think that cosmetic problems are very important health issues. 
+ I believe that the current cosmetic pharmaceutical products are valuable and necessary for my patients. 
Attitudes toward the Advertising of Cosmetic Pharmaceuticals 
+ In general, the new cosmetic pharmaceuticals would be more valuable to my practice if they worked better. 
+ I think it is necessary for pharmaceutical companies to educate patients about cosmetic products before the 
patients go to a physician. 
+ The advertisements I have seen which promote cosmetic pharmaceuticals to c9nsumers are too scientific 
for them to understand. 
+ I would rather the pharmaceutical companies bring up issues such as aging skin and hair loss through 
advertisements so that I do not have to. 
+ I would like to see more advertising of cosmetic products by pharmaceutical companies in the future. 
+ Current advertising of cosmetic pharmaceutical products is too vague for patients to really be motivated to 
see a physician. 
Source: Petroshius, Titus and Hatch, 1995 
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